リウマチ病セミナー III

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

3,850 円(税込)

購入する

商品紹介

患者を長く観察したり追及したりする必要に迫られるので、記録の保存が長くできなければならない。そのようなシステム作りが治療の側で出来ていることが、診断技術や治療法の開発とともに、リウマチ病の治療にはかかせない。しかしながら、すでに得られている確かな情報も多く、日常の診療に生かせるものが数多くあるのも事実である。しかしわれわれにとっては手の届くところで、たやすく利用され得るものでなければメリットがないだろう。以上のようなことを考え、このセミナーを始めさせてもらった。ここにその記録の第3集を刊行できることになり、このうえない喜びとするところである。（序文より）

目次

  • 表紙
  • 執筆者一覧
  • 序文
  • 目次
  • 炎症リウマチ
  • Eosinophilic fasciitis
  • リピト微細結晶性関節炎
  • 慢性関節リウマチと結核
  • Undifferentiated Spondyloarthropathy
  • 1-トリプトファン症候群(好酸球増多-筋痛症候群)
  • Chronic Fatigue Syndrome
  • 蕁麻疹, 血管浮腫と関節炎
  • Hairy cell leukemia
  • 慢性関節リウマチ患者の死因と寿命
  • 骨関節, 神経
  • 膝のintra-osseous synovial cyst(intra-osseous ganglion)と鵞足部滑液包炎
  • 肘の滑液包炎
  • 足趾カギ型変形
  • わが国における骨Paget病の治療
  • Multiple sclerosisとリウマチ症状
  • reflex sympathetic dystrophy-最近の知見-
  • 生物学的反応
  • RAの骨吸収とArthritis Mutilans
  • 成長因子と骨・軟骨
  • 抗SS-A/Ro抗体, 抗SS-B/La抗体
  • 血管内皮細胞と関節炎
  • イディオタイプと抗イディオタイプおよびネットワーク説
  • 治療と副作用
  • 薬剤性リウマチ症候
  • 慢性関節リウマチにおける薬剤性肺罹患
  • RA治療におけるステロイドホルモン
  • MTX(メソトレキセート)療法の実際-血中濃度と副作用-
  • リハビリはリウマチ病の治療にどれだけ役立つか?
  • Rhizolysis-facet denervation
  • 手術
  • 肘の人工関節全置換術
  • 索引
  • DRUG INFORMATION
  • 奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

炎症リウマチ

P.12 掲載の参考文献
1) Shulman LE:Diffuse fasciitis with eosinophilia. a new syndrome? Trans Assoc Am Phisician 88:70-86, 1975
 
2) Rodnan GP, DiBartolomeo AG, Medsger TA, et al:Eosinophilic fasciitis; report of 7 cases of a newly recognized scleroderma-like syndrome. Arth Rheum 18:422-423, 1975
 
3) Torres VM, George WM:Diffuse eosinophilic fasciitis. A new syndrome or variant of scleroderma? Arch Dermatol 113:1591-1593, 1977
PubMed
4) Chanda JJ, Callen JP, Taylor WB:Diffuse fasciitis with eosinophilia. Arch Dermatol 114:1522-1524, 1978
PubMed
5) Moutsopoulus HM, Weber BL, Pavlidis NA, Fostiropoulos G, et al:Diffuse fasciitis with eosinophilia. A clinicopathological study. Am J Med 68:701-709, 1980
 
6) 吉田浩:Shulman 症候群. Medicina 21:1582-1583, 1984
 
7) Jonge-Bok JMD, Steven MM, Eulderink F, et al:Diffuse (eosinophilic) fasciitis. A series of six cases. Clinic Rheumatol 3:365-373, 1984
 
8) Ching DWT, Petrie JP:Childhood eosinophilic fasciitis presenting as inflammatory polyarthritis and associated with selective I & A deficiency. Ann Rheum Disese 50:649-650, 1990
 
9) Degan JA, Hopp RJ, Cassidy JT, et al:Eosinophilic fasciitis in a ten year old boy. Nebraska Med J pp.299-302, 1990
 
10) 吉田彦太郎:Shulman症候群, eosinophilic fasciitis. 皮膚の好酸球浸潤とその周辺 (吉田彦太郎), pp.221-224, 東京, 臨床医薬研究協会, 1990
 
11) Maddison PJ:Eosinophilic fasciitis. British J Rheum 29:81-83, 1990
 
12) 田村多絵子:Eosinophilic fasciitis. 西日皮膚41:1053-1060, 1979
 
13) Tamura T, Saito Y, Ishikawa H:Diffuse fasciitis with eosinophilia; histological and electron microscopic study. Act Dermatovener 59:325-331, 1979
 
14) 石川英―:eosinophilic fasciitis. 皮膚病診療 3:227-230, 1981
 
15) 東威, 井上光洋, 宮城憲―, 他:Morphea様皮疹および好酸球増多症をともなったびまん性筋膜炎の1例. リウマチ 20:88-94, 1980
 
16) 伊東陽子, 水谷仁, 伊東早苗:Eosinophilic Fasciitisの1例. 臨皮 34:871-876, 1980
 
17) 坪井誠吉, 中尾実信, 阪本登:Eosinophilic Fasciitisの1例. 内科 45:163-168, 1980
 
18) 飯塚啓介, 四竃隆男, 楢山幸子, 他:好酸球性筋膜炎の1例. 内科 47:864-867, 1981
 
19) 島田真路, 中林康吉, 滝沢清宏, 他:Eosinophilic fasciitisの1例. 皮膚臨床22:1075-1080, 1980
 
20) 土田哲也, 滝沢清宏, 古江増隆, 他:筋線維周囲にIgG沈着をみた Eosinophilic fasciitisの1例. 日皮会誌91:1311-1319, 1981
 
21) 縄田泰史, 柳沢孝夫, 秋本敏佑, 他:Diffuse Fasciitis with Eosinophiliaの1例-過去報告64例の集計による特徴と病態-. リウマチ 22:219-226, 1982
 
22) 新井佳代, 石川英―, 斉藤義雄, 他:皮下モルフィア (subcutaneous morphea)の1例-好酸球性筋膜炎との異同-. Connective Tissue 14:67-74, 1982
 
23) Nawata Y, Sueishi M, Koike T:Eosinophilic fasciitis with autoimmune features. Arth Rhum 26:688, 1983
 
24) 小泉民雄, 伏見尚子, 岸野文―郎, 他:好酸球性筋膜炎の臨床検討. 住友医誌 10:143-149, 1983
 
25) 片岡和洋, 池田早苗, 高田三枝, 他:Eosinophilic fasciitisの1例, 西日皮膚 45:976-981, 1983
 
26) Yamane K, Ninomiya H, Shabana M, et al:Eosinophilic fasciitis with prominent immunologic abnormalities. Jap Med 22:134-136, 1983
 
27) 山田宏治, 土肥和紘, 花谷正和, 他:好酸球性筋膜炎の1例. 免疫と臨床 7:377-380, 1984
 
28) 石川利之, 長谷哲男, 内山光明, 他:Eosinophilic fasciitis-血液異常および心病変を伴った1症例-. 臨皮 38:851-856, 1984
 
29) 友杉直久, 木田寛, 竹田慎―, 他:好酸球性筋膜炎の2例, 日内会誌 73:1823-1830, 1984
 
30) 生天目英比古, 亀山正邦, 福山秀直, 他:Eosinophilic fasciitis-症例報告と過去104例の検討-. 神経内科 23:153-158, 1985
 
31) 松村勉, 宮川倖子, 阪本邦樹:Diffuse Fasciitis with Eosinophiliaの1例. 臨皮 39:1017-1021, 1985
 
32) 遠藤平仁, 石沢普, 中島偵男, 他:自然寛解を認めた好酸球性筋膜炎の2症例. 埼玉医誌 20:836-839, 1985
 
33) 岡田純, 鈴木貫博, 柏崎偵夫, 他:好酸球性筋膜炎. 免疫病理 3:327-331, 1985
 
34) 鈴木貫博, 岡田純, 柏崎偵夫:好酸球増多と高γ-グロブリン血症を欠如し, クリオグロブリン血症を証明した好酸球性筋膜炎の1例. 北里医学 16:146-150, 1986
 
35) 近藤春樹, 福沢茂, 奥田邦雄, 他:Diffuse Fasciitis with Eosinophiliaの1例. 臨床血液 26:2015-2020, 1985
 
36) 山田明, 森昌夫:末梢神経障害を伴った好酸球性筋膜炎の1例. 診断と治療 74:1402-1412, 1986
 
37) 武田昭, 狩野庄吾:好酸球性筋膜炎. アレルギ―の臨床 6:885-887, 1986
 
38) 木田寛, 友杉直久, 横山仁:好酸球性筋膜炎. Current therapy 5:1496-1499, 1987
 
39) 世古義規, 富谷智明, 黒尾誠, 他:末梢神経障害を伴った eosinophilic fasciitisの1例. 日内会誌 77:370-374, 1988
 
40) 永井寛, 高田任泰, 小川修二, 他:好酸球性筋膜炎の2例. 内科 62:1175-1178, 1988
 
41) 吉岡秀夫, 天野祐―, 金井秀彰, 他:Eosinophilic fasciitisを伴った若年性関節リウマチの1例. 別冊整形外科14 慢性関節リウマチとその周辺疾患 (山本真), pp.43-50, 東京, 文光堂, 1988
 
42) 兼子俊朗, 佐野統, 加藤治樹, 他:ステロイド治療により著明な改善をみた好酸球性筋膜炎の1例. 日臨免誌 11:637-642, 1988
 
43) 桃原茂樹, 伊東恵康, 堀内行雄, 他:右前腕に発症した好酸球性筋膜炎の1例. 臨整外 23:993-996, 1988
 
44) 浜家―雄, 片山治子:好酸球性筋膜炎. 細胞核病理学会雑誌 25:86-86, 1988
 
45) 長田玲子, 堀嘉昭, 中林康青, 他:Shulman症候群の1例. 皮膚臨床 30:369-374, 1988
 
46) 長田玲子, 宇野明彦, 堀嘉昭, 他:Shulman症候群の1例. 皮膚診療 10:423-426, 1988
 
47) 太田―保, 山田滋雄, 塩澤全司, 他:Shulman症候群の筋病理. 神経内科 28:419-421, 1988
 
48) 菊池りか, 檜垣祐子, 肥田野信:好酸球性筋膜炎 Diffuse Fasciitis with Eosinophiliaの1例. 皮膚臨床 31:446-447, 1989
 
49) 滝下佳寛, 坂東康弘, 橋本吉弘, 他:腎機能障害と甲状腺腫をともなった好酸球性筋膜炎の1例. 内科 64:365-368, 1989
 
50) 中岡明久, 上桝次郎, 徳本明秀, 他:CAPD療法の経過中に腹膜炎を契機に発症した好酸球筋膜炎の1例. 鳥取医誌 18:173-176, 1990
 
51) 小川英伸, 荻野谷和裕, 大浦敏博, 他:好酸球性筋膜炎の1 女児例. 小児科診療 9:2169-2174, 1990
 
52) 島田真路, 中林康青, 滝沢清宏, 他:Eosinophilic fasciitisの1例. 皮膚臨床 22:1075-1080, 1980
 
53) 秋月正史:好酸球増多症を伴うびまん性筋膜炎. 診断と治療 69:227-229, 1981
 
54) 宮城憲―, 井上光洋:好酸球性筋膜炎. medicina 18:990-991, 1981
 
55) 岡田純, 柏崎貞夫:進行性全身性硬化症 (PSS)好酸球性筋膜炎 (eosinophilic fasciitis). 臨床検査MOOK20 慢性関節リウマチの検査 (山中学), pp.265-271, 東京, 金原出版, 1985
 
56) 野島美久, 山田明:Eosinophilic fasciitis. 内科 58:940-943, 1986
 
57) 永井寛, 高田任康, 大熊―朝, 他:eosinophilic fasciitis. 皮膚病診療 9:49-52, 1987
 
58) 栗原誠―:Shulman症候群, medicina 25:2112-2113, 1988
 
59) 本間光夫:好酸球性筋膜炎. リウマチ学 (広畑和志), pp.831-833, 東京, 同文書院, 1989
 
60) 吉田俊治, 甕祐史, 鳥飼勝隆:好酸球増多筋膜炎の診療. 臨床免疫 21 (suppl, 14):738-744, 1989
 
61) 岡田純, 柏崎貞夫:好酸球性筋膜炎. 皮膚科 MOOK14強皮症, 皮膚筋炎とその周辺 (西川武二), pp.97-102, 東京, 金原出版, 1989
 
62) 諸井泰興:好酸球性筋膜炎. 最近医学 45:342-345, 1990
 
63) 熊井司, 仲川, 青木孝, 國重義文, 他:好酸球性筋膜炎 (Eosinophilic fasciitis), 整形外科 42:87-89, 1991
 
64) Barnes L, Rodnan GP, Medsger JrTA, et al:Eosinophilic fasciitis; a pathological study of twenty cases. Am J Path 96:493-507, 1979
PubMed
65) Rosenthal J, Benson MD:Diffuse fasciitis and eosinophilia with symmetric polyarthritis. Ann Intern Med 92:507, 1980
PubMed
66) Doyle JA:Eosinophilic fasciitis; extracutaneous manifestations and associations. Cutis 34:259-261, 1984
PubMed
67) Oslon NY, Lindsley CB, et al:Eosinophilic fasciitis presenting as inflammatory polyarthritis. Pediatrics 78:512-514, 1986
 
68) Lakhanpel S, Ginsburg WW, Michet CJ, et al:Eosinophilic fasciitis; clinical spectrum and therapeutic response in 52 cases. Seminers Arth Rheum 17:221-231, 1988
 
69) Loftin EB:Eosinophilic fasciitis. 171 cases reviewed. IMJ 171:289-293, 1987
PubMed
70) Moore TL, Zuckner J:Eosinophilic fasciitis. Semin Arthritis Rheum 9:228-234, 1980
PubMed
71) 岡田純, 鈴木貫博, 他:好酸球性筋膜炎. 免疫薬理 3:327-331, 1985
 
72) Seibold JR, Medsger JrTA, et al:Circulating immune complexes in eosinophilic fasciitis. Arth Rheum 25:1180, 1982
 
73) Campbell ST, Smith DL, Bakke A:Synovial fluid lymphocytes in eosinophilic fasciitis. J Rheum 16:239-241, 1989
 
74) Lynch CJ, Rodnan GP, Singh G, et al:HLA-A and B antigens in eosinophilic fasciitis (letter). J Rheum 8:352-353, 1981
 
75) Suenaga Y, Yasuda M, Tawara T, et al:Eosinophilia with fascial infiltration as early event of a patient with eosinophilic fasciitis. 九州リウマチ 9:156-160, 1990
 
76) Kent LT, Cramer SF, Moskowitz RW:Eosinophilic fasciitis. Clinical, laboratory, and microscopic considerations. Arthritis Rheum 24:677-683, 1981
PubMed
77) Clerk LSD, Degryse HR, Wouters E, Offel JFV, et al:Magnetic resonance imaging in the evaluation of patient with eosinophilic fasciitis. J Rheum 16:1270-1273, 1989
 
78) Caperton EM, Hathaway DE, Dehner LP:Morphea, fasciitis and scleroderma with eosinophilia; A broad spectrum of disease. (abstr), Arthritis Rheum 19:792-793, 1976
 
79) Markusse HM, Breedveld FC:Rheumatoid arthritis with eosinophilic fasciitis and pure red cell aplasia. J Rheumatol 16:1383-1384, 1989
PubMed
80) Naschitz JE, Yeshurun D, Miselevich I, et al:Colitis and pericarditis in a patient with eosinophilic fasciitis. A contribution to the multisystem nature of eosinophilic fasciitis. J Rheum 16:688-692, 1989
 
81) Smiley AH, et al:Eosinophilic fasciitis association with thyroid disease-a report of three cases-. JRheum 7:871, 1980
 
82) Shulman LE, et al:Antibody mediated aplastic anemia and thrombocytopenic purpura in diffuse eosinophilic fasciitis (abstr). Arth Rheum 22:659, 1979
 
83) Hoffman R, Dainiak N, et al:Antibody mediated aplastic anemia and diffuse fasciitis. N Eng J Med 300:718-721, 1979
 
84) Chan LS, Harison CA, Cooper KD:Concurrent eosinophilic fasciitis and cutaneous T-cell lymphpoma. Eosinophilic fasciitis as a paraneoprastic syndrome of T-cell malignant neoplasm? Arch Dermatol 127:862-865, 1991
 
85) Solmon G, Barland P, Rifkin H:Eosinophilic fasciitis responsive to cimetidine. Ann Intern Med 97:547, 1982
 
86) Lao FJ, Pastor I, Castro SD:Cimetidine and eosinophilic fasciitis. Amm Intern Med 98:1026, 1983 (letter)
 
87) Falanga V, Soter NA, Kerdel FA:Increased plasma histamine level in eosinophilic fasciitis. Arc Dermatol 125:805-808, 1989
 
88) Nassonova VA, Ivanova MW, Akhnazarova VD, et al:Eosinophilic fasciitis. Review and report of six cases. Scand J Rheumatol 8:225-233, 1979
 
89) Michet CJJr, Doyle JA, Ginsburg WW:Eosinophilic fasciitis. Report of 15 cases. Mayo Clin Proc 56:27-34, 1981
PubMed
90) Doyle JA, Ginsburg WW:Eosinophilic fasciitis. Med Clinics North Am 73:1157-1166, 1989
 
91) Serratrice G, Pellissier JF, Roux H, et al:Fasciitis, perimyositis, myositis, polymyositis, and eosinophilia. Muscle Nerve 13:385-395, 1990
PubMed
92) Shulman LE:The eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. Arth Rheum 33:913, 1990
 
93) Hardy WR, Anderson RE:The hypereosinophilic syndrome. Ann Inter Med 68:1220-1229, 1968
 
94) 岩田力:hypereosinophilic syndrome. 小児内科 21 臨時増刊号:821-823, 1989
 
95) 名嘉眞武国, 宮里稔, 津田眞五, 他:Hypereosinophilic syndrome. 皮膚の好酸球浸潤とその周辺 (吉田彦太郎), pp.177-190, 1990
 
96) Falanga V, Medsger TA:Frequency, level, and significance of blood eosinophilic fasciitis. Arth Rheum 25:1180, 1982
 
97) Fleischmajer R, Jacotot AB, Shore S, et al:Scleroderma, eosinophilia, and diffuse fasciitis. Arch Dermatol 14:1320, 1978
 
98) Rozboril MB, Mariq HR, Rodnan GP, et al:Capillary microscopy in eosinophilic fasciitis. Arth Rheum 26:617-622, 1983
 
99) Herson S, Brechignac S, Piette JC, et al:Capillary microscopy during eosinophilic fasciitis in 15 patient:Distriction from systemic scleroderma. Am J Med 88:598-600, 1990
 
100) Wasserman SI, Seibold JR, Medsger JrTA, et al:Serum eosinophilotactic activity in eosinophilic fasciitis. Arth Rheum 25:1352-1356, 1982
 
101) Roubenoff R, Cote T, Watson R, et al:Eosinophilia-myalgia syndrome due to L-triptophan ingestion. Report of four cases and review of the Maryland experience. Arth Rheum 33:930, 1990
 
102) Gordano M, Valentini G:Shulmans fasciitis and non-shulman's fasciitis. J Rheum 14:179, 1987
 
103) Markusse HM, Dijkmans BAC, Fibbe WE:Eosinophilic fasciitis after allogeneic bone marrow transplantation. J Rheum 17:692-694, 1990
 
104) Spry CJF:Other cytoplasmic granule constitutents. In Eosinophils; A Comprehensive Review and Guide to the Scientific and Medical Literature. 60, Oxford, Oxford University Press, 1988
 
105) Pincs SH, Ramesh KS, Wyler DJ:Eosinophilic stimulation fibroblast DNA synthesis. Blood 70:572-574, 1987
 
106) 吉田彦太郎:皮膚のアレルギー. 好酸球 (牧野荘平), pp.202-213, 東京, 国際医学出版, 1991
 
107) Stanek G, Kornard K, Jung M, et al:Shulman syndrome, a scleroderma subtype caused by Borrelia burgdorfei? Lanset 1:1490, 1987
 
108) Thompson GTD, MacDougall B, Watson PH:Eosinophilic fasciitis in a pair of siblings. Arth Rheum 32:96-99, 1989
 
P.24 掲載の参考文献
1) Ropes MW, Walter B:Synovial fluid changes in joint diseases. pp. 20-27, Cambridge, Harvard University Press, 1953
 
2) Ettlinger RE, Hunder GG:Synovial effusions containing cholesterol crystals; Report of 12 patients and review. Mayo Clin Proc 54:366-374, 1979
PubMed
3) Goldin DS, Stangler DA, Canoso JJ:Rheumatoid subcutaneous bursitis. J Rheumatol 8:974-978, 1981
PubMed
4) Riordan JW, Dieppe PA:Cholesterol crystals in shoulder synovial fluid. Brit J Rheumatol 26:430-432, 1987
 
5) Fam AG, Pritzker KPH, Cheng PT, et al:Cholesterol crystals in osteoarthritic effusions, J Rheumatol 8:273-280, 1981
 
6) Chauffard A, Wolf M:Structure et evolution des tophus goutteux. Presse Med 31:1013-1015, 1923
 
7) Sokoloff L:The pathology of gout. Metabolism 6:230-243, 1957
PubMed
8) Rodriquez MA:Multiple microcrystal deposition disease in a patient with systemic lupus erythematosus. Ann Rheum Dis 43:498-502, 1984
 
9) 井上康二, 西岡淳一, 福田眞輔, 他:大量のコレステロール結晶を認めた Iliopectineal Bursitisの1例. 日関外誌6:155-162, 1987
 
10) Kieffer D:Manifestations articulaires ou cours des dyslipemies; A propos de deux observations personelles. Rev Rhum Mal Osteoartic 48:569-573, 1981
 
11) Mathon G:Articular manifestations of familial hypercholesterolaemia. Ann Rheum Dis 44:599-602, 1985
PubMed
12) Rooney PJ:Transient polyarthritis with familial hyperbetalipoproteinaemia. Q J Med 67:249-254, 1978
 
13) Bland JH, Gierthy JF, Suhre ED:Cholesterol in connective tissue of joints. Scand J Rheumatol 3:199-203, 1974
PubMed
14) Denko CW, Petricevic M:Modification of cholesterol induced inflammation. Agents Actions 10:353-357, 1980
PubMed
15) Pritzker KPH, Fam AG, Omar SA, et al:Experimental cholesterol crystal arthropathy. J Rheumatol 8:281-290, 1981
 
16) Hasselbacher P, Hahn JL:Activation of the alternative pathway of complement by microcrystalline cholesterol. Arteriosclerosis 37:239-245, 1980
 
17) Small DM:Liquid crystals in living and dying systems. J Colloid Interface Sci 58:581-602, 1977
 
18) Ferguson JL:Liquid crystals. Sci Am 211:77-85, 1964
 
19) Brown GH:Structure and properties of the liquid crystalline stage of matter. J Colloid Interface Sci 58:534-538, 1977
 
20) Small DM, Shipley GG:Physical chemical basis of lipid deposition in atherosclerosis. Science 175:222-229, 1974
 
21) Wild JH, Zvaifler NJ:An office technique for identifying crystals in synovial fluid. Am Fam Physician 12:72-81, 1975
PubMed
22) Reginato AJ, Shumacher HR, Allan DA, et al:Acute monoarthritis associated with lipid liquid crystals. Ann Rheum Dis 44:537-543, 1985
 
23) Weinstein J:Synovial fluid leukocytosis associated with intracellular lipid inclusions, Arch Int Med 140:560-561, 1980
 
24) Schlesinger PA, Stillman MT, Peterson L:Polyarthritis with birefringent lipid within synovial fluid macrophages; Case report and ultrastructural study. Arthritis Rheum 25:1365-1368, 1982
PubMed
25) Trostle DC, Schumacher HR, Medsger TA, et al:Lipid microspherule-associated acute monoarthritis. Arthritis Rheum 29:1166-1169, 1986
 
26) Gardner GC, Terkeltaub RA:Acute monoarthritis associated with intracellular positively birefringent Maltese cross appearing spherules. J Rheumatol 16:394-396, 1989
PubMed
27) Astorga GP, Carvajal PR:Lipid spherule associated arthritis. J Rheumatol 17:1720-1720, 1990
PubMed
28) 石田龍吉, 森下忍, 森田純弘, 他:外傷性関節血症後に発症した液晶lipidによると思われる膝関節炎の一例. 第5回関西リウマチ学会総会プログラム抄録集:91, 1991
 
29) Paul-Moya H, Abadi I:Monoartritis aguda y bursitis olecraneana asociada a liposomas:Artritis porcristales liquidos? IXth PANLAR Congress, Buenos Aires, November 1986
 
30) Roy S, Ghadially FN:Pathology of experimental haemarthrosis. Ann Rheum Dis 26:402-415, 1966
 
31) Choi S-J, Schmacher HR, Clayburne G:Experimental haemarthrosis produces mild inflammation associated with intracellular Maltese crosses. Ann Rheum Dis 45:1025-1028, 1986
 
32) Fiechtner JJ, Simkin PA:Urate spherulites in gouty synovia. JAMA 245:1533-1536, 1981
PubMed
P.34 掲載の参考文献
1) Poncet A, Leriche R:La tuberculose inflammatoire 1 vol, 604p, Paris, Doin, 1912
 
2) 滝沢 始, 小林信之, 石井 彰, 他:膠原病における結核症-合併症としての重要性と鑑別上の問題点-. リウマチ 28:140-144, 1988
 
3) 小宮靖弘, 西岡淳一, 井上康二, 他:抗結核剤投与により症状軽快した慢性関節リウマチの2例. 第6回関西リウマチ学会にて報告 (平成4年)
 
4) McConkey B, Situnayake RD:Effects of rifampicin with and without isoniazid in rheumatoid arthritis. J Rheumatol 15:46-50, 1988
PubMed
5) Konno K, Oizumo K, Oka S:Mode of action of rifampin on mycobacteria. II Biosynthetic studies on the inhibition of ribonucleic acid polymerase of mycobacterium bovis BCG by rifampin and uptake of rifampin-14 C by mycobacterium phlei. Am Rev Resp Dis 107:1006-1012, 1973
 
6) Nilsson BS:Rifampicin:An immunosuppressant? Lancet 2:374, 1971
PubMed
7) Bassi L, Di Berardino L, Arioli V, et al:Conditions for immunosuppression by Rifampicin. J Infect Dis 128:736-744, 1973
PubMed
8) Gupta S, Grieco MH, Siegel I:Suppression of T-lymphocyte rosettes by Rifampin Studies in normals and patients with tuberculosis. Ann Int Med 82:484-488, 1975
PubMed
9) Grassi GG, Pozzi E:Effect of Rifampicin on delayed-hypersensitivity reactions. J Infect Dis 126:542-544, 1972
PubMed
10) 結核病床入院患者の合併症. 結核の統計1990 (厚生省保険医療局結核・感染症対策室 監修) 財団法人結核予防会, 1990
 
11) Minota S, Koyasu S, Yahara I, et al:Autoantibodies to the heat-shock protein HSP90 in systemic lupus erythematosus. J Clin Invest 81:106-109, 1988
 
12) 蓑田清次:Heat Shock Proteinと臨床免疫. 臨床免疫 22:280-285, 1990
 
13) 森尾友宏:rδ型T細胞が主役を演ずる病変. 臨床免疫 22:286-290, 1990
 
14) Van Eden W, Hogervorst EJM, Hensen EJ, et al:A cartilage-mimicking T-cell epitope on a 65K mycobacterial heat-shock protein; Adjuvant arthritis as a model for human rheumatoid arthritis. Current Topics Microbiol Immunol 145:27-43, 1989
 
15) Cohen IR, Weiner H:T-cell vaccination. Immunol Today 9:332-335, 1988
PubMed
16) Asarnow DM, Kuziel W, Bonyhadi M, et al:Limited diversity of γ δ antigen receptor genes of Thy-1+ dendritic epidermal cells. Cell 55:837-847, 1988
 
17) Born W, Happ MP, Dallas A, et al:Recognition of heat shock proteins and γ δ cell function. Immunol Today 11:40-43, 1990
 
18) Janis EM, Kaufmann SHE, Schwartz RH, et al:Activation of γ δ T cells in the primary immune response to mycobacterium tuberculosis. Science 244:713-716, 1989
 
19) Sargent CA, Dunham I, Trowsdale J, et al:Human major histocompatibility complex conteins genes for the major heat shock protein HSP70. Proc Natl Acad Sci USA 86:1968-1972, 1989
 
20) Abrahamsen TG, Froland SS, Natvig JB:In vitro mitogen stimulation of synovial fluid lymphocyte from rheumatoid arthritis and juvenile rheumatoid arthritis patients; dissociation between the response to antigens and polyclonal mitogens. Scand J Immunol 7:81-90, 1978
PubMed
21) Pope RM, Wallis RS, Sailer D, et al:T cell activation by mycobacterial antigens in inflammatory synovitis. Cellular Immunol 133:95-108, 1991
PubMed
22) Palacios-boix AA, Estrada-GI, Colston MJ, et al:HLA-DR4 restricted lymphocyte proriferation to a mycobacterium tuberculosis extract in rheumatoid arthritis and healthy subjects. J Immunol 140:1844-1850, 1988
 
23) Ottenhoff HM, Torres P, De las Aguas JT, et al:Evidence for an HLA-DR4-associated immune-response gene for mycobacterium tuberculosis. A cleu to the pathogenesis of rheumatoid arthritis? Lancet 2:310-312, 1986
 
24) Holoshitz J, Klajman A, Drucker I, et al:T lymphocyte of rheumatoid arthritis patients show augmented reactivity to fraction of mycobacteria cross-reactive with cartilage. Lancet 2:305-309, 1986
PubMed
25) Burford-Foggs AM, Sambol SP, Pope RM:Mechanism of T-cell activation by mycobacterial antigens in inflammatory synovitis. Scand J Immunol 33:253-260, 1991
PubMed
26) De Graeff-Meeder ER, Voorthorst M, Van Eden W, et al:Antibodies to the mycobacterial 65-Kd Heat-Shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritis. Am J Pathol 137:1013-1017, 1990
 
27) Van den Broek MF, Hogervorst EJM, Van Bruggen MCJ, et al:Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-KD mycobacterial heat shock protein. J Exp Med 170:449-466, 1989
 
28) Holoshitz J, Matitiau A, Cohen IR:Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest 73:211-215, 1984
 
29) Lider O, Karin N, Shintzky M, et al:Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure. Proc Natl Acad Sci (USA) 84:4577-4580, 1987
 
30) Lohse AW, Mor F, Karin N, et al:Control of experimental auto-immune encephalomyelitis by T cells responding to activated T cells. Science 244:820-822, 1989
 
P.44 掲載の参考文献
1) Calin A:Spondyloarthropathies; An overview. In Spondyloarthropathies (Ed, Calin A), pp. 1-8, Orlando, Grune & Strattom, 1984
 
2) Zeidler H, et al:Undifferentiated arthritis and spondyloarthropathy as a challenge for prospective studies. Clin Rheumatol 6:112, 1987
PubMed
3) Woodrow JC:Histocompatibility antigens and rheumatic diseases. Semin Arth Rheum 6:257, 1977
 
4) Kellgren JH:Diagnostic criteria for population studies. Bull Rheum Dis 3:291, 1962
 
5) Moll JMH, et al:New York criteria for ankylosing spondylitis. Ann Rheum Dis 32:354, 1973
 
6) van der Linden SM, et al:Evaluation of diagnostic criteria for ankylosing spondylitis; A proposal for modification of the New York criteria. Arthritis Rheum 27:361, 1984
 
7) van der Linden S, et al:Pleliminary criteria for the classification of the spondylarthropathies. Arthritis Rheum 32:47, 1989
 
8) Calin A, et al:The clinical history as a screening test for ankylosing spondylitis. JAMA 237:2613, 1977
PubMed
9) Schattenkrichner M, et al:Natural course and prognosis of HLA B27 positive oligoarthritis. Clin Rheumatol 6:83, 1987
 
10) Dougados M, et al:The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34:1218, 1991
 
11) Amor B, et al:Criteres de classification des spondyloarthropathies. Rev Rhum 57:85, 1990
PubMed
12) Dobost JJ, et al:Rhumatismes seronegatifs a debut tardif. Frequence et atypies des spondylarthropathies. Rev Rhum Mal Osteoartic 58:577, 1991
 
13) Boyer GS, et al:Prevalence rates of spondyloarthropathies, rheumatoid arthritis, and other rheumatic disorders in an Alaskan Inupiat Eskimo population. J Rheumatol 15:678, 1988
 
14) Boyer GS, et al:Spondyloarthropathy and rheumatoid arthritis in Alaskan Yupik Eskimos. J Rheumatol 17:489, 1990
PubMed
P.55 掲載の参考文献
1) Varga J, Peltonen J, Uitto J, et al:Development of diffuse fasciitis with eosillophilia during 1-tryptophan treatment. Ann Intern Med 112:344-351, 1990
 
2) Shulman LE:The eosinophilia-myalgia syndrome associated with ingestion of 1-tryptophan. Arthritis Rheum 33:913-917, 1990
 
3) Martin RW, Duffy J, Engel AG, et al:The clinical spectrum of the eosinophilia-myalgia syndrome associated with 1-tryptophan ingestion. Ann Intem Med 113:124-134, 1990
 
4) Kilbourne EM, Swygert LA, Philen RM, et al:Interim guidance on the eosinophilia-myalgia syndrome. Ann Intern Med 112:85-87, 1990
PubMed
5) Varga J, Heiman-patterson TD, Emery DL, et al:Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome. Semin Arthritis Rheum 19:313-328, 1990
 
6) Hertzman PA, Henry Falk, Kilbourne EM, et al:The Eosinophilia-myalgia syndrome:The Los Alamos Conference. J Rheumatol 18:867-873, 1991
 
7) Freundlich B, Werth VP, Rook AH, et al:L-Tryptophan ingestion associated with eosinophilic faociitis but not progressive systemic sclerosis. Ann Intern Med 112:758-762, 1990
 
8) Medsger TA:Tryptophan induced eosinophilia-myalgia syndrome. N Engl J Med 322:926-928, 1990
PubMed
9) Bulpitt KJ, Verity A, Clements PJ, et al:Association of 1-tryptophan and an illness resembling eosinophilic fasciitis. Arthritis Rheum 33:918-929, 1990
 
10) Belongia EA, Hedberg CW, Gleich GJ, et al:An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 323:357-365, 1990
 
11) Sakimoto K:The cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 323:992-993, 1990
 
12) Crofford LJ, Werth VP, Rook AH, et al:L-Tryprtoplan implicated in human eosinophilia syndrome causes fasciitis and perimyositis in the Lewis Rat. J Clin Invest 86:1757-1763, 1990
 
13) Sternberg EM, Vanvoert MH, Young SN, et al:Development of a scleroderma-like illness during therapy with 1-5-hydroxytryptophan and carbidopa. N Engl J Med 303:782-787, 1980
 
14) Houpt JB, Ogryzio MA, Hunt M:Tryptophan metabolism in man. Semin Arthritis Rheum 2:333-353, 1973
 
15) Silver RM, Heyers MP, Maize JC, et al:Scleroderma, fasciitis and eosinophilia associated with the ingestion of tryptophan. N Engl J Med 322:874-881, 1990
 
16) Roubenoff R, Cote T, Waston R, et al:Eosinophilia-myalgia syndrome due to l-tryptophan ingestion. Arthritis Rheum 33:930-938, 1990
 
P.65 掲載の参考文献
1) Reilly PA, Littlejohn GO:Fibromyalgia and chronic fatigue syndrome. Current Opinn Rheumat 2:282-290, 1990
 
2) Manningham R:The symptoms, nature, causes and cure of the febricula or little fever:commonly called the nervous or hysteric fever; the fever on the spirits; vapours, hypo, or spleen. 2nd ed. London, J. Robinson, pp. 52-53, 1750
 
3) Straus SE:Histry of chronic fatigue syndrome. Rev Infect Dis 13 (Suppl 1) S2-S7, 1991
 
4) Beard GM:A practical treatise on nervous exhausion (neurasthenia). New York:William Wood, 1880
 
5) Beard GM:Neurasthenia, or nervous exhausion. Boston Medical and Surgical Journal:3 (new series) pp. 217-220, 1869
 
6) DaCosta JM:On irritable heart:a clinical study of a form of functional cardiac disorder and its consequence. Am J Med Sci 121:17-52, 1871
 
7) Lewis T:Solidiers heart and the effort syndrome. 2nd ed, London, Shaw Publishing Co, 1940
 
8) Wood P:DaCosta's syndrome (or effort syndrome). BMJ 1:764-772, 1941
 
9) Wood P:DaCosta's syndrome (or effort syndrome). The mechanism of the somatic manifestations. BMJ 1:805-811, 1941
 
10) Wood P:Aetiology of DaCosta's syndrome, BMJ 1:845-851, 1941
 
11) 金山良男:Chronic fatigue syndrome. 臨床科学25:856-862, 1989
 
12) Acheson ED:The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia. Am J Med 26:569-595, 1959
PubMed
13) Richmond C:Myalgic encephalomyelitis, Princess Aurora, and the wondering womb. BMJ 298:1295-1296, 1989
 
14) Barnes DM:Mystery disease at Lake Tahoe challenges virologists and clinicians. Outbreakes of a chronic mononucleosis-like syndrome, a disease that has yet to be well defined, are leading scientists to search for possible causes, which may includes herpes-like viruses. Science 234:541-542, 1986
 
15) 「疲労病」の謎にいどむ. Newsweek日本語版:58-64, 1990年11月11日
 
16) Holmes GP, Kaplan JE, Gantz NM, et al:Chronic fatigue syndrome:A working case definition. Ann Intern Med 108:387-389, 1988
PubMed
17) Holmes GP:Defining the chronic fatigue syndrome. Rev Infect Dis 13 (Suppl 1):S53-S55, 1991
 
18) Lloyd AR, Wakefield D, Boughton C, et al:What is myalgic encephalomyelitis? Lancet 4:1286-1287, 1988
 
19) Komaroff AL, Buchwald D:Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis 13 (Suppl 1):S8-S11, 1991
 
20) Jones JF, Ray CG, Minnich LL, et al:Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illness:elevated anti-early antigen antibodies. Ann Intern Med 102:1-7, 1985
PubMed
21) Bell:unpublished
 
22) 橋本信也, 墨坂大太郎, 丸山道彦:Chronic fatigue syndrome (慢性疲労症候群)-自験例と文献的考察-. 日本医事新報 3491:14-19, 1991年3月23日
 
23) 西海正彦:慢性疲労症候群-自験27症例の検討-. 日本医事新報 3529:43-44, 1991年12月14日
 
24) 橋本信也:慢性疲労症候群の臨床像. モダンメディシン:22-28, 1991年12月
 
25) NHK調査:1991年9月NHK-TVニュースセンター9時より
 
26) Tobi M, Morag A, Ravid Z, et al:Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1:61-64, 1982
 
27) DuBois RE, Seeley JK, Brus I, et al:Chronic mononucleosis syndrome. South Med J 77:1376-1382, 1984
PubMed
28) Salit IE:Sporadic postinfectious neuromyasthenia. Can Med Assoc J 33:659-663, 1985
 
29) Buchwald D, Sullivan JL, Komaroff AL:Frequency of chronic active Epstein-Barr virus infection in a general medical practice. JAMA 257:2303-2307, 1987
 
30) Buchwald D, Komaroff AL:Review of laboratory findings for patient with chronic fatigue syndrome. Rev Infect Dis 13 (Suppl 1):S12-S18, 1991
 
31) Aoki T, Usuda Y, Miyakos H, et al:Low natural killer syndrome:Clinical and immunologic features. Nat Immun Cell Growth Regul 6:116-128, 1987
 
32) Behan PO, Behan WHM, Bell EJ:The postviral fatigue syndrome.-an analysis of the findings in 50 cases. J Infect 10:211-222, 1985
 
33) Caligiuri M, Murray C, Buchwald D, et al:Phenotype and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 139:3306-3313, 1987
PubMed
34) Kibler R, Lucas DO, Hicks MJ, et al:Immune function in chronic active Epstein-Barr virus infection. J Clin Immunol 5:46-54, 1985
PubMed
35) Borysiewicz LK, Haworth SJ, Cohen J, et al:Epstein-Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis. QJ Med 58:111-121, 1986
 
36) Straus SE, Tosato G, Armstrong G, et al:Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 102:7-16, 1985
PubMed
37) Gold D, Bowden R, Sixbey J, et al:Chronic fatigue. A prospective clinical and virologic study. JAMA 264:48-53, 1990
PubMed
38) Prieto J, Subira ML, Castilla A, et al:Naloxone-reversible monocyte dysfunction in patients with chronic fatigue syndrome. Scand J Immunol 30:13-20, 1989
PubMed
39) Buchwald D, Komaroff AL:unpublished.
 
40) Weinstein L:Thyroiditis and "chronic infectious mononucleosis" [letter]. New Eng J Med 317:1225-1226, 1987
PubMed
41) Komaroff AL:unpublished.
 
42) Buchwald D, Komaroff AL:unpublished.
 
43) Lloyd AR, Wakefield D, Boughton CR, et al:Immunological abnormalities in the chronic fatigue syndrome. Med J Aust 151:122-124, 1989
PubMed
44) DuBois RE, Seely JK, Brus I, et al:Chronic mononucleosis syndrome. South Med J 77:1376-1382, 1984
 
45) Roubalova K, Roubal J, Skopovy R, et al:Antibody response to Epstein-Barr virus antigens in patients with chronic viral infection. J Med Virol 25:115-122, 1988
 
46) Read R, Spickett Q, Harvey J, et al:IgG1 subclass deficiency in patients with chronic fatigue syndrome[letter]. Lancet 1:241-242, 1988
 
47) Tosato G, Straus S, Henle W, et al:Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol 134:3082-3088, 1985
PubMed
48) Buchwald D, Komaroff AL:unpublished.
 
49) Kaslow JE, Rucker L, Onishi R:Liver extract-folic acid-cyanocobalamin vs. placebo for chronic fatigue syndrome. Arch Intern Med 149:2501-2503, 1989
PubMed
50) Komaroff AL:unpublished.
 
51) Murdoch JC:Cell-mediated immunity in patients with myalgic encephalomyelitis syndrome. N Z Med 101:511-512, 1988
 
52) Buchwald D, Komaroff AL:unpublished.
 
53) Kroenke K, Wood DR, Mangelsdorff AD, et al:Chronic fatigue in primary care; prevalence, patient characteristics, and outcome. JAMA 260:929-934, 1988
PubMed
54) Holmes GP, Kaplan JE, Stewart JA, et al:A cluster of patients with a chronic mononucleosis-like syndrome; Is Epstein-Barr virus the cause? JAMA 257:2297-2302, 1987
PubMed
55) Hotchin NA, Read R, Smith DG, et al:Active Epstein-Barr virus infection in post-viral fatigue syndrome, J Infect 18:143-150, 1989
PubMed
56) Waters-Peacocke N, Wray BB, Ades EW:A prospective study; evaluation of the antibody-dependent cell-mediated cytotoxicity assay in chronic active Epsein-Barr syndrome. J Clin Lab Immunol 27:11-12, 1988
PubMed
57) Evans AS:Chronic fatigue syndrome; Thoughts on pathogenesis. Rev Infect Dis 13 (Suppl 1):S56-S59, 1991
 
58) Kiecolt-Glaser JK, Fisher LD, Ogrocki P, et al:Marital quality, marital disrupsion, and immune function. Psychosom Med 49:13-34, 1987
PubMed
59) Kiecolt-Glaser JK, Glaser R, Shuttleworth EC, et al:Chronic stress and immunity in family caregivers of Alzheimer's disease victims. Psychosom Med 49:523-535, 1987
PubMed
60) Diaz-Mitoma F, Vanast WJ, Tyrell DLJ:Increased frequency of Epsein-Barr virus excresion in patients with new daily persistent headaches, Lancet 1:411-415, 1987
 
61) Glaser R, Strain EC, Tarr KH, et al:Changes in Epstein-Barr virus antibody that associated with aging. Proc Soc Exp Biol Med 179:351-352, 1985
 
62) Landay AL, Jessop C, Lennette ET, Levy JA:Chronic fatigue syndrome; clinical condition associated with immune activation. Lancet 338:707-711, 1991
PubMed
63) Straus SE, Dale JK, Tobi M, et al:Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. New Engl J Med 319:1692-1698, 1988
 
64) Peterson PK, Shepard J, Macres M, et al:A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med 89:554-560, 1991
 
65) Lloyd A, Hickie I, Wakefield D, et al:A doubl-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med 89:561-568, 1991
 
66) Chronic fatigue syndrome-false avenues and dead ends. Lancet 337:331-332, 1991
PubMed
67) Manu P, Lane TJ, Matthews DA:The frequency of the chronic fatigue syndrome in patients with symptoms of persistent fatigue. Ann Intern Med 109:554-556, 1988
PubMed
68) 座談会:木谷照夫, 西海正彦, 花輪壽彦, 松田重三, 山本直樹. 慢性疲労症候群と漢方. 漢方医学16:297-310, 1992.
 
69) (週刊) 病院新聞. 1992年2月27日
 
P.75 掲載の参考文献
1) Dover JS, Black AK, Ward AM, et al:Delayed pressure urticaria. J Am Acad Dermatol 18:1289-1298, 1988
PubMed
2) Czarnetzki BM, Meentken J, Rosenbach T, et al:Clinical, pharmacological and immunological aspects of delayed pressure urticaria. Brit J Dermatol 111:315-323, 1984
 
3) Klofkorn RW & Lehman TJA:Eosinophilic synovial effusions complicating chronic urticaria and angioedema. Arthritis Rheum 25:708-709, 1982
 
4) Brown JP, Rola-Pleszczynski and Menard HA:Eosinophilic synovitis; Clinical observations on a newly recognized subset of patients with dermatographism.
 
5) McNeil DJ, Kinsella TD, Crawford AM, et al:The AHA syndrome; arthritis, hives and angioedema. Rheumatol Int 7:277-279, 1987
PubMed
6) Agnello V, Koffler D, Eisenberg JW, et al:Clq precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states; characterization of high and low molecular weight types. J Exp Med 134:228 (S)-241 (S), 1971
 
7) Mc Duffie FC, Sam WM, Maldonado JE, et al:Hypocomplementemia with cutaneous vasculitis and arthritis; possible immune complex syndrome, Mayo Clin Proc 48:340-348, 1973
 
8) Schwartz HR, McDuffie FC, Black LF, et al:Hypocomplementemic urticarial vasculitis; association with chronic obstructive pulmonary disease. Mayo Clin Proc 57:231-238, 1982
PubMed
9) Zeiss CR, Burch FX, Marder RJ, et al:A hypocomplementemic vasculitic urticarial syndrome; report of four new cases and difinition of the disease. Am J Med 68:867-875, 1980
 
10) Marder RJ, Burch FX, Schmid FR, et al:Low molecular weight Clq-precipitins in hypocomplementemic vasculitis-urticaria syndrome; partial purification and characterization as immunoglobulin. J Immunol 121:613-618, 1978
 
11) Ruzicka T and Goerz G:Systemic lupus erythematosus and vasculitic urticaria:effect of Dapson and complement levels. Dermatol 162:203-205, 1981
 
12) Tuffanell DL and Dubois EL:Cutaneous manifestations of systemic lupus erythematosus. Arch Dermatol 90:377-386, 1964
 
13) Bywaters EGL:Still's disease in the adult. Ann Rheum Dis 30:121-133, 1971
 
14) Elkon KB, Hughes GRV, Bywater EGL, et al:Adult-onset Still's disease; twenty-year follow-up and further studies of patients with active disease. Arthritis Rheum 25:647-654, 1982
 
15) Gammon WR, Clayton MD, Wheeler Jr CE:Urticarial vasculitis; report of a case and review of the literature. Arch Dermatol 115:76-80, 1979
 
16) 多田譲治:慢性関節リウマチ患者にみられたurticarial vasculitis. 皮膚臨床 27:401-404, 1985
 
17) 古川隆代, 甲原資秀, 小林勝, 他:慢性関節リウマチに併発した蕁麻疹様血管炎-DDSが奏効した1例-. 皮膚臨床 32:1213-1217, 1990
 
18) 藤平正利, 林懋, 川田陽弘, 他:リウマチ熱にみられた蕁麻疹様皮疹について-組織学的 Leukocytoclastic vasculitisを呈した1例-. 皮膚臨床 23:1709-1713, 1981
 
19) Gorevic PD:Cryopathies:Cryoglobulins and Cryofibrinogenemia. In Immunological Diseases (ed by Samter M, Talmage DW, Frank MM, et al). pp. 1687-1713, Boston/Toronto, Lillte, Brown and Company, 1988
 
20) Muckle TJ:The "Muckle-Wells, syndrome". British J Dermat 100:87-92, 1979
 
P.82 掲載の参考文献
1) Bouroncle BA, Wiseman BK, Doan CA:Leukemic reticuloendotheliosis. Blood 13:609-630, 1958
PubMed
2) Schrek R, Donnelly WJ:"Hairy" cells in blood in lymphoreticular neoplastic disease and "fiagellated" cells of normal lymph nodes. Blood 27:199-211, 1966
PubMed
3) Korsmeyer SJ, Greene WC, Cossman J, et al:Rearrangement and expression of immunoglobulin of Fac antigen in hairy cell leukemia. Proc Natl Acad Sci USA 80:4522-4526, 1983
 
4) Anderson KC, Boyd AW, Fisher DC:Hairy cell leukemia; A tumor of preplasma cells. Blood 65:620-629, 1985
 
5) Burns GF, Cawley JC, Worman CP, et al:Multiple heavy chain isotypes on the surface of the cells of hairycell leukemia. Blood 52:1132-1147, 1978
 
6) Jansen J, den Ottolander GJ, Schuit HRE, et al:Hairy cell leukemia; Its place among the chronic B cell leukemias. Semin Oncol 11:386, 1984
 
7) Schwarting R, Stein H, Wang CY:The monoclonal antibodies S-HCL 1 (Leu-14) and S-HCL 3 (Leu-M 5) allow the diagnosis of hairy cell leukemia. Blood 65:974-983, 1985
 
8) Posnett DN, Chiorazzi N, Kunkel HG:Monoclonal antibodies with specificity for hairy cell leukemia cells. J Clin Invest 70:254-261, 1982
 
9) Visser L, Shaw A, Slupsky J, et al:Monoclonal antibodies reactive with hairy cell leukemia. Blood 74:320-325, 1989
PubMed
10) Yam LT, Janckila AJ, Li CY, et al:Cytochemistry of tartrate resistant acid phosphatase; 15 years' experience. Leukemia 1:285-288, 1987
PubMed
11) Drexler HG, Gaedicke G, Minowada J:Isoenzyme studies:in human leukemia-lymphoma cells lines 11. Acid phosphatase. Leuk Res 9:537-548, 1985
 
12) Mulligan SP, Matutes E, Dearden C, Catovsky D:Splenic lymphoma with villous lymphocytes; natural history and response to therapy in 50 cases. Br J Haematol 78:206-209, 1991
PubMed
13) 木谷照夫, 待井隆志, 徳嶺進洋:Hairy cell leukemia. 血液・腫瘍科 22:213-222, 1991
 
14) Mulligan SP:Human B cells; differentiation and neoplasia. Leukaemia and Lymphoma 1:275-291, 1990
 
15) Doane LL, Ratain MJ, Golomb HM:Hairy cell leukemia; Current management. Hematol Oncol Clin North Am 4:489-502, 1990
PubMed
16) Flandrin G, Sigaux F, Sebahoun G, Bouffette P:Hairy cell leukemia; Clinical presentation and follow-up of 211 patients. Semin Oncol 14 (suppl. 2):13-17, 1987
 
17) Kraut EH, Bouroncle BA, Grever MR:Low-dose deoxycoformycin in the treatment of hairy cell leukemia. Blood 68:1119-1122, 1986
PubMed
18) Piro LD, Carrera CJ, Carson DA, Beutler E:Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxy adenosine. N Engl J Med 322:1117-1121, 1990
 
19) Elkon KB, Hughes GRV, Catovsky D, et al:Hairy-cell leukemia with polyarteritis nodosa. Lancet ii:280-282, 1979
 
20) Crofts MAJ, Sharp JC, Joyner MV:Rheumatoid arthritis and hairy-cell leukemia. Lancet ii:203-204, 1979
 
21) Manna R, Perri F, Ghirlanda G, et al:Association of ankylosing spondylitis with hairy cell leukemia; a previously once reported case. Z Rheumatol 44:93-96, 1985
PubMed
22) Westbrook CA, Golde DW:Clinical problems in hairy cell leukemia; diagnosis and management. Semin Oncol 11:514-522, 1984
PubMed
23) Lie JT:Isolated polyarteritis of testis in hairy-cell leukemia. Arch Pathol Lab Med 112:646-647, 1988
PubMed
24) Farcet JP, Wechslere J, Wirquin V, Divine M, Reyes F:Vasculifis in hairy cell leukemia. Arch intern Med 147:660-664, 1987
 
25) Salvarani C, Capozzoli N, Baricchi R, et al:Auto-immune disease in hairy cell leukemia; systemic vasculitis and anticardiolipin syndrome. Clin Exp Pheumatol 7:329-377, 1989
 
26) Posnett DN, Marboe CC, Knowles DM:A membrane antigen (HCL) selectively present on hairy cell leukemia cells, endothelial cells and epidermal basal cells. J Immunol 15:658-659, 1984
 
27) Klima M, Waddell CC:Hairy cell leukemia associated with focal vascular dammage. Hum Pathol 15:658-659, 1984
 
28) Demanes DJ, Lane N, Beckstead JH:Bone involvement in hairy-cell leukemia. Cancer 49:1697-1701, 1982
PubMed
29) Quesada JR, Keating MJ, Libshitz HI, Llamas L:Bone involvement in hairy cell leukemia. Am J Med 74:228-231, 1983
PubMed
30) Arkel YS, Lake-Lewin D, Savopoulos AA, Berman E:Bone lesions in hairy cell leukemia; a case report and response of bone pains to steroids. Cancer 53:2401-2403, 1984
PubMed
31) Herold CJ, Wittich GR, Schwarzinger I, Haller J, Chott A, Mostbeck G:Sleletal involvement in hairy cell leukemia. Sleletal Radiol 17:171-175, 1988
 
32) Lembersky BC, Ratain MJ, Golomb HM:Skeletal complications in hairy cell leulemia; diagnosis and therapy. J Clin Oncol 6:1280-1284, 1988
PubMed
33) Rhyner K, Streuli R, Kistler GS:Huarzell-Leukamie mit osteo lyfischen Knochen Veranderungen. Schweiz Med Wschr 107:863-871, 1977
 
P.94 掲載の参考文献
1) 七川歓次, 前田晃, 吉野良平, 他二慢性関節リウマチの死因調査. 昭和52年度, 骨･関節難病調査研究会研究結果, pp. 7-9, 大阪府衛生部, 大阪府特定疾患研究会, 大阪骨・関節難病研究会. 昭和53年3月, 1978
 
2) 大田寛, 七川歓次, 吉野良平, 他:慢性関節リウマチの死因調査 (300死亡例).平成2年度特定疾患調査研究結果報告書, 骨, pp. 48-66, 大阪府環境保健部, 大阪府特定疾患研究会, 大阪骨･関節難病研究会, 平成3年3月, 1992
 
3) Cobb S, Anderson F, Bauer W:Length of life and cause of death in rheumatoid arthritis. N Engl J Med 249:553-556, 1953
PubMed
4) Reah TG:The prognosis of rheumatoid arthritis. Proc R Soc Med 56:813-817, 1963
PubMed
5) Vandenbroucke JP, Hazevoet HM, Cats A:Survival and cause of death in rheumatoid arthritis; a 25 year prospective follow-up. J Rheumatol 11:158-161, 1984
PubMed
6) Mitchell DM, Spitz PW, Young DY, et al:Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 29:706-714, 1986
PubMed
7) Linos A, Worthington JW, O' Fallon WN, et al:The Epidemiology of rheumatoid arthritis in Rochester, Minnesota; a study of incidence, prevarence and mortality. Am J Epidemiol 111:87-98, 1980
 
8) Eulderink P:Klinische les Doodsoorzaak Rheumatoide Arthritis. Ned Tijdschr geneeskd 120:357-363, 1976
 
9) Constable TJ, McConkey B, Paton A:The cause of death in rheumatoid arthritis. Ann Rheum Dis 37:569, 1978
 
10) 大田寛, 七川歓次, 前田晃:慢性関節リウマチの死因調査, リウマチ 19:641, 1979
 
11) Rasker JJ, Cosh JA:Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis. Ann Rheum Dis 40:115-120, 1981
 
12) 浅井富明, 古沢久俊, 三宅信昌, 他:下肢機能再建術と生命予後. リウマチ科 2:813-820, 1989
 
13) 吉澤久嘉, 工藤洋, 岩野邦男, 他:慢性関節リウマチの死因に関する研究-117死亡例の分析-. リウマチ30:255-263, 1990
 
14) Reilly PA, Cosh JA, Maddison PJ, et al:Mortality and survival in rheumatoid arthritis:a 25 year prospective study of 100 patients, Ann Rheum Dis 49:363-369, 1990
PubMed
15) 辻林啓幸, 膳棟造, 津山研―郎, 他:在宅ねたきりRA患者の死亡調査第6回関西リウマチ学会総会抄録平成4年3月7日大阪, 1992
 
16) 古沢久俊, 浅井富明, 長屋郁郎:RA手術と機能予後, 生命予後. 関節外科 11:359-365, 1992
 
17) Van Dam G, Lezwijn A, Bos JG:Death-rate of patients with rheumatoid arthritis. Atti del X Congresso della lega Internazionale Contro il Rheumatismo, Roma, 3-7 September, 1961. Vol. I. Relazioni. Minerva Medica. Torino, Italy, 1961, p. 161.
 
18) Duthie JJR, Brown PE, Truelove LH, et al:Course and prognosis in rheumatoid arthritis. A further report. Ann Rheum Dis 23:193, 1964
 
19) Uddin J, Kraus AS, Kelly G:Survivorship and death in rheumatoid arthritis. Arthritis rheum 13:125-130, 1970
 
20) Rosenberg EF, Baggenstoss AH, Hench PS:The causes of death in thirty causes of rheumatoid arthritis. Ann Int Med 20:903-919, 1944
 
21) Mitchell D:Epidemiology. In Rheumatoid arthritis (Eds. Utsinger PD, Zvaifler NJ, Ehrlich GE), pp. 133-150, Philadelphia, Lippincott Co, 1985
 

骨関節, 神経

P.106 掲載の参考文献
1) Bauer TW, Dorfman HD:Intraosseous ganglion. A clinicopathologic study of 11 cases. Am J Surg Pathol 6:207-213, 1982
PubMed
2) Schajowicz F, Sainz MC, Sullitel JA:Juxta-articular bone cysts (intraosseous ganglia). A clinicopathological study of eighty-eight cases. J Bone and Joint Surg 61B:107-116, 1979
 
3) Fairbank HAT, Lloyd EI:Cysts of the external cartilage of the knee with erosion of the head of the tibia. British J Surg 22:115-118, 1934
 
4) Crane AR, Scarano JJ:Synovial cysts (ganglia) of bone; Report of two cases. J Bone and Joint Surg 49A:355-361, 1967
 
5) Feldman F, Johnston A:Intraosseous ganglion. Am J Roentgenol 118:328-343, 1973
 
6) Goldman RL, Friedman NB:Ganglia ("synovial" cysts) arising in unusual locations. Report of 3 cases, One primary in bone. Clin Orthop 63:184-189, 1969
PubMed
7) Hicks JD:Synovial cysts in bone. Australian and New Zealand J Surg 26:138-143, 1956
 
8) Kambolis C, Bullough PG, Jaffe HL:Ganglionic cystic defects of bone. J Bone and Joint Surg 55A:496-505, 1973
 
9) Willems D, Mulier JC, Martens M, et al:Ganglion cysts of bone. report of two cases and review of the literature. Acta Orthop Scandinavica 44:655-662, 1973
 
10) 日本整形外科学会骨軟部腫瘍委員会:全国骨腫瘍患老登録―覧表 (昭和61年), 1986
 
11) Matsumoto K, Hukuda S and Ogata M:Juxta-articular bone cysts at the insertion of the pes anserinus; Report of two cases. J Bone and Joint Surg 72A:286-290, 1990
 
12) 西野嘉人, 石澤命仁, 岩崎淳, 他:距骨に生じた骨内ガングリオンの1症例. 整災外 34:1597-1600, 1991
 
13) Moschcowitz E:Bursitis of sartorius bursa:An undescribed malady simulating chronic arthritis. JAMA 109:1362, 1937
 
14) Blookler M, Mongan ES:Anserine bursitis; A treatable cause of knee pain in patients with degenerative arthritis. California Med 119:8-10, 1973
 
15) Bywaters EGL:Lesions of bursae, tendons and tendon sheaths. Clin Rheumat Dis 5:883-925, 1979
 
16) Insall JN:Surgery of the Knee. New York, Churchill Livingstone, 1984
 
17) Larsson L-G, Baum J:The syndrome of anserina bursitis; An overlooked diagnosis. Arthrit and Rheumat 28:1062-1065, 1985
 
18) Pinals RS:Traumatic arthritis and allied conditions. In Arthritis and Allied Conditions. A Textbook of Rheumatology (Ed, McCarty DJ), pp. 1205-1222, Philadelphia, Lea and Febiger, 1985
 
19) Turek SL:The knee. In Orthopaedics. Principles and Their Application. Ed. 4 Vol. 2, pp. 1269-1406, Philadelphia, JB Lippincott, 1984
 
20) Lee KR, Cox GG, Neff JR, et al:Cystic masses of the knee; Arthrographic and CT evaluation. Am J Roentgenol 148:329-334, 1987
 
21) Hall FM, Joffe N:CT imaging of the anserine bursa. Am J Roentgenol 150:1107-1108, 1988
 
22) Maksimovic B, Nonicic D:Bursitis anserina. Acta Rheumatologia Belgradensia 7:147-151, 1977
 
23) Voorneveld C, Arenson AG, Fam AG:Anserine bursal distension; Diagnosis by ultrasonography and computed tomography. Arthrit and Rheumat 32:1335-1338, 1989
 
24) 鈴木敏雄:成人及ビ新産児ノ膝関節附近ノ滑液嚢ニツイテ. 東京医学雑誌 52:810-826, 1938
 
25) Voshell AF:Anatomy of the knee joint. In Instructional Course Lectures; The American Academy of Orthopaedic Surgeons. Vol 13, pp. 246-247, Saint Louis, The C. V. Mosby Company, 1956
 
P.115 掲載の参考文献
1) 白岡 格, 柴田大法:XXVIII. 関節外リウマチ, 1. 関節周囲の疾患. リウマチ学 (塩川優一編), pp. 1095-1104, 東京, 同文書院, 1989
 
2) 森 於菟, 大内弘:VI. 上肢の筋, 5. 上肢の滑液包, 解剖学1, 改訂第10版, pp. 354-355, 東京, 金原出版, 1977
 
3) Canoso JJ:Bursal membrane and fluid. Laboratory Diagnostic Procedures in the Rheumatic Disease (Ed. Cohen AS), pp. 55-76, Orland, Grune and Stratton, 1985
 
4) Canoso JJ:Bursitis, tenosynovitis, ganglions, and painful lesion of the wrist, elbow, and hand. Current Opinion in Rheumatology 2:276-281, 1990
 
5) Ho G Jr, Mikolich DJ:Bacterial infection of the superficial subcutaneous Bursae. Clin Rheum Dis 12:437-457, 1986
PubMed
6) Roschmann RA, Bell CL:Septic bursitis in immunocompromised patients. Am J Med 83:661-665, 1987
PubMed
7) Buskila D, Tenenbaum J:Septic bursitis in human immunodeficiency virus infection. J Rheumatol 16:1374-1376, 1989
PubMed
8) Canoso JJ:Bursae, tendon and ligaments. Clin Rheum Dis 7:189-221, 1981
 
9) Karanjia ND, Stiles PJ:Cubital bursitis. J Bone Joint Surg [Br] 70B:832-83, 1988
 
10) Ehrlich GE:Antecubital cysts in rheumatoid arthritis; corollary to popliteal (Baker's) cysts. J Bone Joint Surg 54A:165-169, 1972
 
11) Weiner SR, Szydlo L, Fan P:Synovial cyst presenting as forearm mass. Postgr Med 72:258-261, 1982
 
12) Resnick D:Diagnosis of Bone and Joint Disorders (Ed. Resnick D, Niwayama G), pp. 880-882, Philadelphia, Saunders, 1981
 
13) Doube A, Gow PJ:Bicipital swelling in adult on set still's disease. Br J Rheumatol 26:216-217, 1987
 
14) Keret D, Porter KM:Synovial cyst and ulnar nerve entrapment. Clin Orthop 188:213-216, 1984
PubMed
15) Ishikawa H, Hirohata K:Posterior interosseous nerve syndrome associated with rheumatoid synovial cysts of the elbow joint. Clin Orthop 254:134-139, 1990
PubMed
16) Kamien M:A rational management of tennis elbow. Sports Med 9:173-191, 1990
PubMed
17) Goldie I:Epicondylitis lateralis; Acta Chirurgica Scandanavica. suppl 339:104-109, 1964
 
18) Briggs CA, Elliott BG:Lateral epicondylitis; a review of structures associated with tennis elbow. Anat Clin 7:149-153, 1985
PubMed
P.124 掲載の参考文献
1) 辻本正記:足の変形. 関節外科 4:367-372, 1985
 
2) Vainio K:The rheumatoid foot. Ann Chirur Gynaec 45 (Suppl 1), 1956
 
3) 小野田太郎:リウマチ足に関する臨床的研究. 岡山医会誌 77:113-125, 1975
 
4) 木村千仭:リウマチにおける足の変形. 整･災外 28:1341-1347, 1985
 
5) 山本学ら:RA前足変形の検討. 日関外誌 8:87-94, 1989
 
6) 吉川玄逸, 辻本正記, 谷仁孝:リウマチ足趾変形に対する術後療法. 関節外科 8:75-80, 1989
 
P.137 掲載の参考文献
1) Paget J:On a form of chronic inflammation of bones (osteitis deformans). Med Chir Trans 60:37-64, 1977 (2より引用)
 
2) Singer FR:Paget's disease of bone. Plenum Medical New York, pp. 17-21, 1977
 
3) O' Driscoll JB, Anderson DC:Past pets and Paget's disease. Lancet 2:919-921, 1985
PubMed
4) Mills BC, Singer FR:Critical evalution of viral antigen data in Paget's disease of bone. Clin Orthop 217:16-25, 1987
 
5) Siris ES, Kelsey JL, Flaster E, et al:Paget's disease of bone and previous pet ownship in the United States exonerated. Int J Epidemiol 19:455-458, 1990
 
6) Schmorl G:uber osteitis deformans Paget. Virchows Arch Path Anat 283:694-751, 1932
 
7) Collins DH:Paget's disease of bone, incidence and subcinical forms. Lancet 2:51-57, 1956
 
8) Pygott F:Paget's disease of bone, the radiological incidence. Lancet 1:1170-1171, 1957
 
9) Newman FW:Paget's disease. J Bone Joint Surg 28:798-804, 1946
PubMed
10) Rosenkrans JA, Wolf J, Kaicher JJ:Paget's disease (Osteitis deformans) Review of one handred and eleven cases. AMA Arch inten Med 90:610-633, 1952
 
11) Barry HC:Paget's disease of bone. Baltimore, Willams and Wilkins 1969 (2より引用)
 
12) 小松原良雄:骨paget病. 隔月刊関節外科 4:51-56, 1985
 
13) Teitelbaum SL:The pathology of Paget's disease of bone-clinical assessment, present and future therapy-(Ed. Singer FR, Wallach S), pp, 29-43, New York, Elsevier, 1991
 
14) Haibach H, Farrell C, Dittrich FJ:Neoplasmo arising in Paget's disease of bone-A study of 82 cases AJCP 83:594-600, 1983
PubMed
15) Huvos AG:Osteogenic sarcoma of bone and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years. Cancer 57:1442-1449, 1986
 
16) Singer FR, Krane SM:Paget's disease of bone Metabolic bone disease and clinical related disorders. (Ed. Avioli LV, Krane SM), pp. 546-615, Philadelphia, WB Saunders, 1990
 
17) Singer FR, Ginger K:Resistance of calcitonin. Paget's disease of bone-clinical assessment, present and future therapy (Ed. Singer FR, Wallach S), pp. 75-85, New York, Elsevier, 1991
 
18) 横井徹, 林英紀, 小松原良雄:骨Paget病のカルチトニンによる治療経過. 中部整災誌 25:1301-1303, 1982
 
19) Alexandre C, Chapuy MC, Vignon E, et al:Treatment of Paget's disease of bone with ethane-1, Hydroxy-1, 1 diphosphonate (EHDP) at a low dosage (5mg/k/day). Clin Orthop 174:193-205, 1983
 
20) Meunier PJ, Ravault A:Treatment of Paget's disease with etidronate disodium. Paget's disease of bone-clinical assessment, present and future therapy. (Ed. Singer FR., Wallach S), pp. 86-99, New York, Elsevier, 1991
 
21) 小松原良雄, 三村利博, 小倉浩:骨Paget病の治療に関する研究-EHDPの治療効果の検討-. 昭和59年度特定疾患調査研究結果報告書, 大阪府衛生部骨. pp. 6-12, 1985
 
22) 鳥塚莞爾, 古川洋太郎, 吉川靖三, 他:骨Paget病に対するEHDP (Etidronate disodium)の臨床効果. 基礎と臨床 23:1375-1385, 1989
Medical*Online
23) McDonald DJ, Sim FH:Total hip arthroplasty in Paget's disease; a follow-up note. J Bone Joint Surg 69A:766-772, 1987
 
24) Merkow RL, Pellicci PM, Hely DP, et al:Total hip replacement for Paget's disease of the hip. J Bone Joint Surg 66A:752-758, 1984
 
P.145 掲載の参考文献
1) 柴崎浩:多発性硬化症の疫学. 神経進歩 33:778-789, 1989
 
2) 黒岩義五郎:多発性硬化症の臨床. 日内会誌 70:1363-1375, 1981
 
3) 斎田孝彦, 太田光煕, 川西健登, 他:多発性硬化症, 内科 58:944-950, 1986
 
4) Shifodaria PV, Haire M, Fleming E, et al:Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol 44:1237-1241, 1987
 
5) 斎田孝彦:多発性硬化症とHAM. 臨床神経学 28:1382-1383, 1988
 
6) 田平武:多発性硬化症. 臨床医 15:22-24, 1989
 
7) Keyser JD:Autoimmunity in multiple sclerosis. Neurology 38:371-374, 1988
 
8) 内藤説也:多発性硬化症とHLA. 神経内科 23:427-433, 1985
 
9) Hubault A, Roucoules J:Aspects rheumatologiques de la sclerose en plaques. Actualite Rhumatologique 27:141-152, 1990
 
10) Clifford DB, Trotter JL:Pain in multiple sclerosis. Arch Neurol 41:1270-1273, 1984
PubMed
11) Moulin DE, Foley KM, Ebers GC:Pain syndromes in multiple sclerosis. Neurology 38:1830-1834, 1988
PubMed
12) Moulin DE:Pain in multiple sclerosis. Neurol Clin 7:321-331, 1989
PubMed
13) Kassirer MR, Osterberg DH:Pain in multiple sclerosis. Am J Nurs 36:968-969, 1987
 
14) Vermote R, Ketelaer P, Carton H:Pain in multiple sclerosis patients. Clin Neurol Neurosurg 88:87-93, 1986
PubMed
15) Giroud M, Guard O, Aidry D, et al:Une manifestation mal connue de la sclerose en plaques; la sciatalgier. Ann Med Intern 15:1512-1515, 1985
 
16) Schumacher GA:Problems of experimental trials of therapy in multiple sclerosis; report by the panel on the evaluation of experimental therapy in multiple sclerosis. Ann NY Acad Sci 122:552-568, 1965
 
17) 吉良潤―, 糸山泰人:多発性硬化症. 診断と治療 12:3117-3122, 1989
 
18) Cartel JL, Rodriguez M:Immunosuppressive treatment in multiple sclerosis. Mayo Clin Proc 64:664-669, 1989
 
19) Bornstein MB, Miller A, Slagle S, et al:A pilot trial of cop1 in exacerbating-remitting multiple sclerosis. N Engl J Med 317:408-414, 1987
 
20) Seyfert S, Klapps P, Meisel C, et al:Multiple sclerosis and other immunologic diseases. Acta Neurol Scand 81:37-42, 1990
PubMed
21) Thomas DJ, Kendall MJ, Whitfield AGW:Nervous system involvement in ankylosing spondylitis. Br Med J 26:148-150, 1974
 
22) Khan MA, Kushner I:Ankylosing spondylitis and multiple sclerosis. Arthritis Rheum 22:784-786, 1979
PubMed
23) Pillay N, Hunter T:Delayed evoked potentials in patients with ankylosing spondylitis. J Rheumatol 13:137-141, 1976
 
24) Hanrahan PS, Russell AS, McLean DR:Ankylosing spondylitis and multiple sclerosis; an apparent association? J Rheumatol 15:1512-1514, 1988
PubMed
25) Alexander EL, Marinow K, Lejewski JE, et al:Primary Sjogren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 104:323-330, 1986
 
26) 矢吹聖三, 柏原健―:多発性硬化症と類似の中枢神経症状を示したSjogren症候群の2例. 神経内科 26:572-577, 1987
 
27) 田中正美, 成田美和子, 馬場広子, 他:Sjogren症候群を伴った多発性硬化症. 神経内科 23:277-280, 1985
 
28) Metz LM, Seland TP, Fritzler MJ, et al:An analysis of the frequency of Sjogren's syndrome in a population of multiple sclerosis patients. J Clin Lab Immunol 30:121-125, 1989
 
29) Miro J, Pena-Sngredo JL, Berciano J, et al:Prevalence of primary sjogren's syndrome in patients with multiple sclerosis. Ann Neurol 27:582-584, 1990
 
30) Noseworthy JH, Bss BH, Vandervoort MK, et al:The Prevalence of primary Sjogren's syndrome in a multiple sclerosis population. Ann Neurol 25:95-98, 1989
 
P.152 掲載の参考文献
1) Patman RD, Thompson JE, Persson AV:Management of post-traumatic pain syndromes; report of 113 cases. Ann Surg 177:780-787, 1973
PubMed
2) Schwartzman RJ, McLellan TL:Reflex sympathetic dystrophy. Arch Neurol 44:555-561, 1987
PubMed
3) Schutzer SF, Gossling HR:The treatment of reflex sympathetic dystrophy syndrome. J Bone Joint Surg 66A:625-629, 1984
 
4) Rodriguez-Moreno J, Ruiz-Martin JM, Mateo-Soria L, et al:Munchausen's syndrome simulating reflex sympathetic dystrophy. Ann Rheum Dis 49:1010-1012, 1990
PubMed
5) Silber TJ:Anorexia nervosa and reflex sympathetic dystrophy syndrome. Psychosomatics 30:108-111, 1989
PubMed
6) Zucchini M, Alberti G, Moretti MP:Algodystrophy and related psychological features. Func Neurol 4:153-156, 1989
 
7) Roig-Escofet J, Rodriguez-Moreno J, Martin JMR:Concept and limits of the reflex sympathetic dystrophy. Clin Rheum 8:104-108, 1989
 
8) Michaels RM, Sorber JA:Reflex sympathetic dystrophy as a probable paraneoplastic syndrome; case report and literature review. Arthr Rheum 27:1183-1185, 1984
 
9) Huaux JP, Sonnet J, Bigaignon G, et al:Arthrite de Lyme et algodystrophie sympathique reflexe; une association exceptionnelle mais logique. Rev Rheum 55:781-783, 1988
 
10) Neumann RA, Aberer E, Stanek G:Evidence for spirochetal origin of Sudeck:satrophy (algodystrophy, reflex sympathetic dystrophy). Arch Orthop Traum Surg 108:314-316, 1989
 
11) Schott G:Clinical features of algodystrophy; is the sympathetic nervous system involved? Func Neurol 4:131-134, 1989
 
12) Ochoa J:The newly recognized painful ABC syndrome; thermographic aspects. Thermology 2:65-107, 1986
 

生物学的反応

P.159 掲載の参考文献
1) 七川歓次, 奥和美:ムチランス型RAの病態. 近畿リウマチ病研究会講演集 1:11-21, 1990
 
2) Stursberg H:Uber verstummelnde Gelenkentzundung. Dtsche Med Wschr 6:5-7, 1935
 
3) Ochi T, Iwase R, Yonemasu K, et al:Naturalcourse of joint destruction and fluctuation of serum Clq levels in patients with rheumatoid arthritis. Arthritis Rheum 31:37-43, 1988
 
4) Sambrook PN, Ansell BM, Foster S, et al:Bone turnover in early rheumatoid arthritis. 2. Longitudinal bone density studies. Ann Rheum Dis 44:580-584, 1985
PubMed
5) Shimizu S, Shiozawa S, Shiozawa K, et al:Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum 28:25-31, 1985
PubMed
6) Takashima T, Kawwai K, Hirohata K, et al:Inflammatory cell changes in Harversian canal. J Bone Joint Surg 71-B:671-676, 1989
 
7) Dequeker J and Geusens P:Osteoporosis and arthritis. Ann rheumatic Dis 49:276-280, 1990
 
8) Gowen M and Mundy GR:Acton of recombinant interleukin 1, interleukin 2 and interferon r on bone resorbtion in vitro. J Immunol 136:2478-2482, 1986
 
9) Robinson DR, Tashian AM, Levin L:Prostaglandin stimulated bone resorption by rheumatoid synovia. J Clin Invest 56:1181-1188, 1975
 
10) Mizel SB, Dayer JM, Krane SM, et al:Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin-1) Proc Natl Acad Sci 78:2474-2477, 1981
PubMed
11) Goldings SR, Roekle MS, Petrison KK, et al:Interleukin 1 mediates effects of soluble monocytemacrophage products on responses to prostaglandin E2; a potential mechanism for regulating cellular activity at sites of inflammation. J B one Mineral Res 1, 55A, 1986
 
12) Thomson BM, Saklavala J, Chambers TJ:Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med 164:104-112, 1986
PubMed
13) Stashenko P, Dewhirst FE, Rooney ML, et al:Interleukin-1 is a potent inhibitor of bone formation in vitro. J Bone Mineral Res 2:559-565, 1987
 
14) Ishimi Y, Miyaura C, He Jin C, et al:IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303, 1990
 
P.166 掲載の参考文献
1) 加藤幸夫, 島津篤, 中島和久, ほか:軟骨細胞の増殖･分化の調節. 実験医学 7:1279-1285, 1989
 
2) 特集/TGF-βファミリー:腫瘍増殖因子の構造と機能. 実験医学 8(4), 羊土社, 東京, 1990
 
3) Noda M, Camilliere JJ:In vivo stimulation of bone formation by transforming growth factor-β. Endocrinology 124:2991-2994, 1989
 
4) 米田俊之:骨のリモデリングにおけるtransforming growth factor-betaの役割. The Bone 5:27-35, 1991
 
5) Urist MR:Bone; Formation by autoinduction. Science 150:893-899, 1965.
PubMed
6) Takaoka K, Ono K, Amitani K, et al:Solubilization and concentration of a bone-inducing substance from a murine osteosarcoma. Clin Orthop 148:274-280, 1980
PubMed
7) Wozney JM, Rosen V, Celeste AJ, et al:Novel regulators of bone formation; Molecular clones and activities. Science 242:1528-1534, 1988
PubMed
8) Luyten FP, Cunningham NS, Ma S, et al:Purification and partial amino acid sequence of osteogenin; a protein initiating bone differentiation. J Biol Chem 264:13377-13380, 1989
PubMed
9) Sampath TK, Coughlin JE, Whetstone RM, et al:Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-β superfamily. J Biol Chem 265:13198-13205, 1990.
 
10) Yamaguchi A, Katagiri T, Ikeda T, et al:Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681-687, 1991
PubMed
11) 丹羽峰雄, 高倉昭治:IGF-I, II と結合蛋白. The Bone 5:45-54, 1991
 
12) 三井洋司, 今村亨:FGFと新規ECGFによる血管系細胞の増殖制御. 細胞増殖因子の基礎と臨床 (清水信義, 高久史麿編), pp. 1237-1246, 東京, 共立出版, 1991
 
13) Cuevas P, Burgos J, Baird A:Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem Biophys Res Comm 156:616-618, 1988
 
P.174 掲載の参考文献
1) Clark G, Reichlin M, Tomasi TB:Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 102:117-122, 1969
 
2) Mattioli M, Reichlin M:Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus; Description of a cytoplasmic nonribosomal antigens. Arthritis Rheum 17:421-429. 1974
 
3) Alspaugh MA, Tan EM:Antibodies to cellular antigens in Sjogren's syndrome. J Clin Invest 55:1067-1073, 1975
 
4) Akizuki M, Powers RJr, Holman HR:A soluble acidic protein of the cell nucleus which reacts with serum from patients with systemic lupus erythematosus and Sjogren's syndrome. J Clin Invest 59:264-272, 1977
 
5) Alspaugh MA, Maddison P:Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjogren's syndrome:an interlaboratory collaboration. Arthritis Rheum 22:796-798, 1979
 
6) Sontheimer RD, Lieu TS, McCauliffe DP:Molecular characterization of the Ro/SS-A autoimmune response. Seminars in Dermatol 10:199-205, 1991
 
7) Ben-Chetrit E, Chan EKL, Sullivan KF, Tan EM:A 52KD protein is a novel component of the SS-A/Ro antigen particle. J Exp Med 167:1560-1571, 1988
 
8) Rader MD, O:Brian C, Liu Y, Harley JB, Reichlin M:Heterogeneity of the Ro antigen. J Clin Invest 83:1293-1298, 1989
 
9) Ben-Chetrit E, Gandy BJ, Tan EM, Sullivan KF:Isolation and characterization of a cDNA clone encoding the 60-KD component of the human SS-A/Ro ribonucleoprotein autoantigen. J Clin Invest 83:1284-1292, 1989
 
10) Chan EK, Sullivan KF, Fox RI, Tan EM:Sjogren's syndrome nuclear antigen B (La); cDNA cloning, structural domains, and autoepitopes. J Autoimmun 2:321-327, 1989
 
11) Gottlieb E, Steitz JA:The RNA binding protein La influences both the accuracy of RNA polymerase III transcription in vitro. EMBO J 8:841-850, 1989
PubMed
12) Gottlieb E, Steitz JA:Function of the mammalian La protein; evidence for its action in transcription termination by RNA polymerase III. EMBO J 8:851-861, 1989
PubMed
13) Chambers JC, Kenan D, Martin BJ, et al:Genomic structure and arhino acid sequence domains of the human La autoantigen. J Biol Chem 263:18043-18051, 1988
PubMed
14) Chan EK, Sullivan KF, Fox RI, et al:Sjogren's syndrome nuclear antigen B (La); cDNA cloning, structural domains, and autoepitopes. J Autoimmun 2:321-327, 19?9
 
15) Kohsaka H, Yamamoto K, Fujii H, et al:Fine epitope mapping of the human SS-B/La protein. Identification of a distinct antoepitope homologous to a viral gag polyprotein. J Clin Invest 85:1566-1574, 1990
 
16) 橋本武則, 全明:原発性シェーグレン症候群-綜説及び自験202例の統計的解析. 皮膚 31:627-642, 1989
 
17) Alexander EL, Arnett FC, Provost TT, Stevens MB:Sjogren's syndrome:Association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 98:155-159, 1983
 
18) Ben-Chetrit E, Fox RI, Tan EM:Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjogren's syndrome, Arthritis Rheum 33:349-355, 1990
 
19) Furukawa F, Lyons MB, Lee LA, Coulter SN, Norris DA:Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus. J Immunol 141:1480-1488, 1988
 
20) Furukawa F, Kashihara-Sawami M, Lyons MB, Norris DA:Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL):Implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 94:77-85, 1990
 
21) Sontheimer RD, Thomas JR, Gilliam JN:Subacute cutaneous lupus erythematosus; A cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 115:1409-1415, 1979
PubMed
22) Sontheimer RD:Subacute cutaneous lupus erythematosus; A decade's perspective. Med Clin North Amer 73:1073-1090, 1989
 
23) Petri M, Watson R, Hochberg MC:Anti-Ro antibodies and neonatal lupus. Rheum Dis Clin North Am 15:335-360, 1989
PubMed
24) 丹治修, 長谷川隆哉, 金子史男:新生児エリテマトーデス. 臨床皮膚科45 (5増):12-17, 1991
 
25) 石丸咲恵, 伊崎誠―, 北村啓次郎, 森田豊:新生児エリテマトーデス-母体へのステロイド投与により房室ブロックの消失をみた1例. 臨床皮膚科 45:751-755, 1991
 
26) Singsen BH, Navon P, Wang G, Sharp GC:Anti-SSa and other antinuclear antibodies (ANA) in healthy pregnant women and in newborn cord bloods. J Rheumatol 13:984, 1986
 
27) Alexander E, Buyon JP, Provost TT, Guamieri T:Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum 35:176-189, 1992
 
28) Buyou JP, Winchester R:Congenital complete heart block; A human model of passively acquired autoimmune injury. Arthritis Rheum 33:609-614, 1990
 
P.185 掲載の参考文献
1) Fiebig E, Ley K, Arfors KE:Rapid leukocyte accumulation by spontaneous rolling and adhesion in the exteriorized rabbit mesentery. Int J Microcirc Clin Exp 10:127-144, 1991
PubMed
2) Springer TA:Adhesion receptors of the immune system. Nature 346:425-434, 1990
PubMed
3) Chin JE, Winterrowd GE, Krzesicki RF, Sanders ME:Role of cytokines in inflammatory synovitis. The coordinate regulation of intercellular adhesion molecule 1 and HLA class I and class II antigens in rheumatoid synovial fibroblasts. Arthritis Rheum 33:1776-1786, 1990
 
4) Anderson DC, Springer TA:Leukocyte adhesion deficiency; an inherited defect in the Mac-1, LFA-1, and p. 150, 959 glycoproteins. Ann Rev Med 38:175-194, 1987
 
5) Hale LP, Martin ME, McCollum DE, Nunley JA, Springer TA, Singer KH, Haynes BF:Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment. Arthritis Rheum 32:22-30, 1989
PubMed
6) Amaout MA:Leukocyte adhesion molecules deficiency; its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol Rev 114:145-180, 1990
 
7) Hibbs ML, Xu H, Stacker SA, Springer TA:Regulation of adhesion to ICAM-1 by the cytoplasmic domain of LFA-1 integrin β subunit. Science 251:1611-1613, 1991
 
8) Allen CA, Highton J, Palmer DG:Increased expression of p150, 95 and CR3 leukocyte adhesion molecules by mononuclear phagocytes in rheumatoid synovial membranes. Comparison with osteoarthritic and normal synovial membranes. Arthritis Rheum 32:947-954, 1989
PubMed
9) Hemler ME, Elices MJ, Parker C, Takada Y:Structure of the integrin VLA-4 and its cell-cell and cell matrix adhesion functions. Immunol Rev 114:45-65, 1990
PubMed
10) Shiozawa K, Shiozawa S, Shimizu S, Fujita T:Fibronectin on the surface of articular cartilage in rheumatoid arthritis. Arthritis Rheum 27:615-622, 1984
PubMed
11) Shiozawa S, Yoshihara R, Kuroki Y, Fujita T, Shiozawa K, Imura S:Pathogenic significance of fibronectin in the superficial region of articular cartilage as a local factor for the induction of pannus extension on rheumatoid articular cartilage. Ann Rheum Dis 5:869-873, 1992
 
12) 松山隆美:リウマチと接着分子. Medical Immunology 20:601, 1990
 
13) Haynes BF, Hale LP, Denning SM, Le PT, Singer KH:The role of leukocyte adhesion molecules in cellular interactions; Implications for the pathogenesis of inflammatory synovitis. Springer Semin Immunopathol 11:163-185, 1989
PubMed
14) Shimizu Y, van Seventer GA, Horgan KJ, Shaw S:Regulated expression and binding of three VLA (β1) integrin receptors on T cells. Nature 345:250-253, 1990
 
15) Holzmann B, McIntyre BW, Weissman IL:Identification of a murine Peyer's patch-specific lymphocyte homing receptor as an integrin molecule With an a chain homologous to human VLA-4 a. Cell 56:37-46, 1989
 
16) Osborn L, Hession R, Tizard C, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R:Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds lymphocytes. Cell 59:1203-1211, 1989
 
17) Koch AE, Burrows JC, Haines GK, Carlos TM, Harlan JM, Leibovich SJ:Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest 64:313-320, 1991
PubMed
18) Laffon A, Garcia-Vicuna R, Humbria A, Postigo AA, Corbi AL, de Landazuri MO, Sanchez-Madrid F:Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J Clin Invest 88:546-552, 1991
PubMed
19) Lawrence MB, Springer TA:Leokocytes roll on a selectin at physiologic flow rates; distinction from and prerequisite for adhesion through integrins. Cell 65:859-873, 1991
 
20) Williams AF:Out of equilibrium. Nature 352:473-474, 1991
PubMed
21) Picker LJ, Warnock RA, Burns AR, Doerschuk CM, Berg EL, Butcher EC:The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. Cell 66:921-933, 1991
 
22) Phillips ML, Nudelman E, Gaeta FC, Perez M, Singhal AK, Hakomori S, Paulson JC:ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 250:1130-1132, 1990
PubMed
23) Rosenstein Y, Park JK, Hahn WC, Rosen FS, Bierer BE, Burakoff SJ:CD43, a molecule defective in Wiscott-Aldrich syndrome, binds ICAM-1. Nature 354:233-235, 1991
PubMed
24) 丸山征郎:血管内皮細胞と凝固･線溶. 臨床免疫 23:1-9, 1991
 
25) 佐藤靖史:サイトカインによる血管内皮細胞の増殖調節. 臨床免疫 23:32-38, 1991
 
26) 松原司, 広畑和志:炎症における血管新生の調節. 臨床免疫 23:46-57, 1991
 
27) Schreiber AB, Winkler ME, Derynck R:Transforming growth factor-α; A more potent angiogenic mediator than epidermal growth factor. Science 232:1250-1253, 1986
 
28) Shiozawa S, Shiozawa K, Tanaka Y, Morimoto I, Uchihashi M, Fujita T, Hirohata K, Hirata Y, Imura S:Human epidermal growth factor for the stratification of synovial lining layer and neovascularization in rheumatoid arthritis. Ann Rheum Dis 48:820-828, 1989
PubMed
29) Ziff M:Role of endothelium in chronic inflammation. Springer sem Immunopathol 11:199-214, 1989
 
P.191 掲載の参考文献
1) Jeme NK:Toword a network theory of the immune system. Ann Immunol (Paris) 125C:373-389, 1974
 
2) Bona CA:Idiotypic Networks. Fundamental Immunology (Ed. Paul WE), pp. 577-592, NY, Raven Press, 1984
 
3) Abbas AK, Lichtman AH and Pober JS:Cellular and Molecular Immunology. pp. 215-221, Saunders Co, 1991
 
4) Roitt IM, Brostoff J, Male DK:免疫学イラストレイテッド第2版, pp. 125-134, 南江堂, 1990
 
5) 柴田忍, 佐々木毅:イディオタイプ免疫ネットワークと抗イディオタイプ抗体.日本臨牀 48:821-827, 1990
Medical*Online
6) 佐々木毅:イディオタイプネットワークの異常と自己免疫. Medical Immunolog 23:363-369, 1992
 
7) Sasaki T, Muroi T, Takai O, et al:Binding specificity of anti-idiotypic autoantibodies to anti-DNA antibodies in humans. J Clin Invest 82:748-754, 1988
 
8) Berkman SA, Lee ML, Gale RP:clinical uses of intravenous immunoglobulins. Anh Int Med 112:278-292, 1990
 
9) Stiehm ER:New uses for intravenous immnue globulin. N E J Med 325:123-125, 1991
 

治療と副作用

P.203 掲載の参考文献
1) Jacobs RP:Drug-induced rheumatic diseases. Compr Ther 10:65-72, 1984
PubMed
2) Lawson JP:Drug-induced lesions of the musculoskeletal system. Radiol Clin North Am 28:233-246, 1990
PubMed
3) Lohr KM:Rheumatic manifestations of diseases associated with substance abuse. Semin Arthritis Rheum 17:90-111, 1987
PubMed
4) Ragab AH, Frech RS, Vietti TJ:Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer 25:580-585, 1970
PubMed
5) Schwartz AM, Leonidas JC:Methotrexate osteopathy. Skeletal Radiol 11:13-16, 1984
PubMed
6) Fallon MP, Perry III HM, Bergfeld M, et al:Exogenous hyperthyroidism with osteoporosis. Arch Intern Med 143:442-444, 1983
 
7) Hahn TJ:Drug-induced disorders of vitamin D and mineral metabolism. Clin Endocrinol Metab 9:107-127, 1980
PubMed
8) Llewellyn CH, Resnik CS, Brower AC:Case report 288. Skeletal Radiol 12:223-226, 1984
PubMed
9) Mastaglia FL:Adverse effects of drugs on muscle. Drug 24:304-321, 1982
PubMed
10) Zuckner J:Drug-induced myopathies. Semin Arthritis Rheum 19:259-268, 1990
 
11) Carroll GJ, Will RK, Peter JB, et al:Penicillamine induced polymyositis and dermatomyositis, J Rheumatol 14:995-1001, 1987
PubMed
12) Takahashi K, Ogita T, Okudaira H, et al:D-penicillamine-induced polymyositis in patients with rheumatoid arthritis. Arthritis Rheum 29:560-564, 1986
PubMed
13) Halla JT, Fallahi S, Koopman WJ:Penicillamine-induced myositis, observations and unique features in two patients and review of the literature. Am J Med 77:719-722, 1984
PubMed
14) Afifi AK, Bergman RA, Harvey JC:Steroid myopathy. Clinical, histologic, and cytologic observations. Johns Hopkins Med J 123:158-174, 1968
PubMed
15) Dubois EL:Triamcinolone in the treatment of systemic lupus erythematosus. JAMA 167:1590-1599, 1958
 
16) Askari A, Vignos Jr PJ, Moskowitz RW:Steroid myopathy in connective tissue disease. Am J Med 61:485-492, 1976
 
17) Khaleeli AA, Edwards RHT, Gohil K, et al:Corticosteroid myopathy; A clinical and pathological study. Clin Endocrinol 18:155-166, 1983
 
18) Kuncl RW, Duncan G, Watson D, et al:Colchicine myopathy and neuropathy. N Engl J Med 316:1562-1568, 1987
PubMed
19) Kuncl RW, Duncan G:Chronic human colchicine myopathy and neuropathy. Arch Neurol 45:245-246, 1988
PubMed
20) Estes ML, Ewing-Wilson D, Chou SM, et al:Chloroquine neuromyotoxicity; Clinical and pathologic perspective. Am J Med 82:447-455, 1987
PubMed
21) Goy JJ, Stauffer JC, Deruaz JP, et al:Myopathy as possible side-effect of cyclosporin. Lancet I:1446-1447, 1989
PubMed
22) Noppen M, Velkeniers B, Dierckx R, et al:Cyclosporine and myopathy. Ann Intern Med 107:945-946, 1987
PubMed
23) Curran JJ, Jamieson TW:Dermatomyositis-like syndrome associated with phenylbutazone therapy. J Rheumatol 14:397-398, 1987
PubMed
24) Leventhal LJ, Ktiritsky L, Ginsburg R, et al:Salicylate-induced rhabdomyolysis. Am J Emerg Med 7:409-410, 1989
 
25) Langer T, Levy RI:Acute muscular syndrome associated with administration of clofibrate. N Engl J Med 279:856-858, 1968
PubMed
26) Bridgman JF, Rosen SM, Thorp JM:Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia. Lancet 2:506-509, 1972
PubMed
27) Pierides AM, Alvarez-Ude F, Kerr DNS:Clofibrate:induced muscle damage in patients with chronic renal failure. Lancet 2:1279-1282, 1975
 
28) Goldman JA, Fishman AB, Lee JE, et al:The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis. Arthritis Rheum 32:358-359, 1989
PubMed
29) Jensen OB, Mosdal C, Reske-Nielsen E:Hypokalemic myopathy during treatment with diuretics. Acta Neurol Scand 55:465-482, 1977
PubMed
30) Basser LS:Purgatives and periodic paralysis. Med J Aust 1:47-48, 1979
PubMed
31) Drutz DJ, Fan JH, Tai TY, et al:Hypokalemic rhabdomyolysis and myoglobinuria following amphotericin B therapy. JAMA 211:824-825, 1970
PubMed
32) Powell JR:Steroid and hypokalemic myopathy after corticosteroids for ulcerative colitis. Am J Gastroenterol 52:425-432, 1969
PubMed
33) 森本靖彦, 中島智子:甘草製剤による偽アルドステロン症のわが国における現状. 和漢医薬学会誌 8:1-22, 1991
 
34) Watson AJS, Dalbow MH, Stachura I, et al:Immumologic studies in cimetidine-induced nephropathy and polymyositis. N Engl J Med 308:142-145, 1983
 
35) Shergy WJ, Caldwell DS:Polymyositis after propylthiouracil treatment for hyperthyroidism. Ann Rheum Dis 47:340-343, 1988
PubMed
36) Kale SA:Drug-induced systemic lupus erythematosus. differentiating it from the real thing. Postgrad Med 77:231-242, 1985
PubMed
37) Lee SL, Chase PH:Drug-induced systemic lupus erythematosus:A critical review. Semin Arthritis Rheum 5:83-103, 1975
PubMed
38) Solinger AM:Drug-related lupus. Clinical and etiologic considerations. Rheum Dis Clin North Am 14:187-202, 1988
PubMed
39) Totoritis MC, Rubin RL:Drug-induced lupus. genetic, clinical, and laboratory features. Postgrad Med 78:149-161, 1985
PubMed
40) Weinstein A:Drug-induced systemic lupus erythematosus. Prog Clin Immunol 4:1-21, 1980
PubMed
41) Perry HM Jr, Tane M, Carmody S, et al:Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine. J Lab Clin Med 76:114-125, 1970
 
42) Blomgren SE, Condemi JJ, Bignall MC, et al:Antinuclear antibody induced by procainamide. A prospective study. N Engl J Med 281:64-66, 1969
PubMed
43) Rothfield NF, Bieren WF, Garfield JW:Isoniazid induction of antinuclear antibodies. A prospective study. Ann Intern Med 88:650-652, 1978
 
44) Cush JJ, Goldings EA:Southern internal medicine conference:drug-induced lupus:clinical spectrum and pathogenesis. Am J Med Sci 290:36-45, 1985
 
45) 西海正彦, 杉本正毅, 佐藤昭雄, 他:日本人におけるprocainamideとhydralazineによる薬物誘発性抗核抗体に関する研究.日内会誌 76:60-62, 1987
 
46) 宮脇昌二, 小野寺英明, 坂本賢司:薬剤誘発ループス. 西日皮膚第48巻, pp. 428-435, 1986
 
47) Sunahara S, Urano M, Ogawa M:Genetical and geographic studies on isoniazid inactivation. Science 134:1530, 1961
 
48) Perry HM Jr, Tan EM, Carmody S, et al:Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine. J Lab Clin Med 76:114-125, 1970
PubMed
49) Woosley RL, Drayer DE, Reidenberg MM, et al:Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med 298:1157-1159, 1978
PubMed
50) Alarcon-Segovia D, Fishbein E, Alcala H:Isoniazid acetylation rate and development of antinuclear antibodies upon isoniazid treatment. Arthritis Rheum 14:748-752, 1971
PubMed
51) Batchelor JR, Welsh KI, Tinoco RM, et al:Hydralazine-induced systemic lupus erythematosus; influence of HLA-DR and sex on susceptibility. Lancet 1:1107-1109, 1980
PubMed
52) Luna MA, Bedrossian CWM, Lichtiger B, et al:Interstitial pneumonitis associated with bleomycin therapy. Am J Clin Pathol 58:501-510, 1972
 
53) Finch WR, Podnan GP, Buckingham RB, et al:Bleomycin-induced scleroderma. J Rheumatol 7:651-659, 1980
 
54) Medsger TA Jr:Tryptophan-induced eosinophilia-myalgia syndrome. N Engl J Med 322:926-928, 1990
PubMed
55) Spiera H:Scleroderma after silicone augmentation mammoplasty. JAMA 260:236-238, 1988
PubMed
56) Kumagai Y, Shiokawa Y, Medsger TA Jr, et al:Clinical spectrum of connective tissue disease after cosmetic surgery:observations on eighteen patients an review of the Japanese literature. Arthritis Rheum 27:1-12, 1984
PubMed
57) 塩川優一, 西野義久, 島田唆介, 他:乳房形成術後おこった, いわゆるヒトAdjuvant病と思われる症例. 臨床免疫 4:389-396, 1972
 
58) Steen VD, Medsger TA Jr, Rodnan GP:D-penicillamine therapy in progressive systemic sclerosis (Scleroderma) A retrospective analysis. Ann Intern Med 97:652-659, 1982
PubMed
59) Miyagawa S, Yoshioka A, Hatoko M, et al:Systemic sclerosis-like lesions during long-term penicillamine therapy for Wilson's disease. Br J Dermatol 116:95-100, 1987
PubMed
60) Mullick FG, McAllister HA Jr, Wagner BM, et al:Drug related vasculitis. clincopathologic correlations in 30 patients. Hum Pathol 10:313-325, 1979
 
61) Shalit M, Flugelman MY, Harats N, et al:Quinidine-induced vasculitis. Arch Intern Med 145:2051-2052, 1985
PubMed
62) Gemmill JD, Sandler M, Hillis WS, et al:Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Br Heart J 60:361, 1988
PubMed
63) Drago F, Arditi M, Rebora A:Tamoxifen and purpuric vasculitis. Ann Intern Med 112:965-966, 1990
PubMed
64) Choe U, Rothschild BM, Laitman L:Ciprofloxacin-induced vasculitis. N Engl J Med 320:257-258, 1989
PubMed
65) Huminer D, Cohen JD, Majadla R, et al:Hypersensitivity vasculitis due to ofloxacin. Br Med J 299:303, 1989
 
66) Wei N:Flurbiprofen and cutaneous vasculitis. Ann Intern Med 112:550-551, 1990
PubMed
67) Carrasco MD, Riera C, Clotet B, et al:Cutaneous vasculitis associated with propylthiouracil therapy. Arch Intern Med 147:1677, 1987
PubMed
68) Bergman SM, Krane NK, Leonard G, et al:Azathioprine and hypersensitivity vasculitis. Ann Intern Med 109:83-84, 1988
PubMed
69) Marks CR, Willkens RF, Wilske KR, et al:Small-vessel vasculitis and methotrexate. Ann Intern Med 100:916, 1984
PubMed
70) Segal R, Caspi D, Tishler M, et al:Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Arthritis Rheum 31:1182-1185, 1988
PubMed
71) Citron BP, Halpern M, McCarron M, et al:Mecrotizing angiitis associated with drug abuse. N Engl J Med 283:1003-1011, 19707
 
72) Epstein EH, McNutt NS, Beallo R, et al:Severe vasculitis during isotretinoin therapy. Arch Dermatol 123:1123-1125, 1987
PubMed
73) Case records of the Massachusetts General Hospital, Case 17-1986. N Engl J Med 314:1170-1184, 1986
PubMed
74) Dwyer JM, Kenicer K, Thompson BT, et al:Vasculitis and retinoids. Lancet II:494-496, 1989
 
75) Wing SS, Fantus IG:Adverse immunologic effects of antithyroid drugs. CMAJ 136:121-127, 1987
PubMed
76) Cohen MG, Kevat S, Prowse MV, et al:Two distinct quinidine-induced rheumatic syndromes. Ann Intern Med 108:369-371, 1988
PubMed
77) Savola J:Arthropathy induced by beta blockade. Br Med J 287:1256-1257, 1983
 
78) Machtey I:Polyarthritis following propranolol. Arthritis Rheum 24:568-569, 1981
PubMed
79) Waller PC, Ramsay LE:Do p blockers cause arthropathy? A case control study. Br Med J 291:1684, 1985
 
80) Kaplan R, Robinson CA, Scavulli JF, et al:Propranolol and the treatment of rheumatoid arthritis. Arthritis Rheum 23:253-255, 1980
PubMed
81) Kirby CP:Treatment of simple urinary tract infections in general practice with a 3-day course of norfloxacin. J Antimicrob Chemother 13 (Suppl B):107-112, 1984
PubMed
82) Alfaham M, Holt ME, Goodchild MC:Arthropathy in a patient with cystic fibrosis taking ciprofioxacin. Br Med J 295:699, 1987
 
83) Walker RC, Wright AJ:The Quinolones. Mayo Clin Proc 62:1007-1012, 1987
PubMed
84) Seaman JM, Goble M, Madsen L, et al:Fasciitis and polyarthritis during antituberculous therapy. Arthritis Rheum 28:1179-1184, 1985
 
85) Pfinsgraff J, Buckingham RB, Killian PJ, et al:Palmar fasciitis and arthritis with malignant neoplasms; A paraneoplastic syndrome. Semin Arthritis Rheum 16:118-125, 1986
PubMed
86) Frame B, Jackson CE, Reynolds WA, et al:Hypercalcemia and skeletal effects in chronic hypervitaminosis A. Ann Intern Med 80:44-48, 1974
PubMed
87) Wilson DJ, Kay V, Charig M, et al:Skeletal hyperostosis and extraosseous calcification in patients receiving long-term etretinate (Tigason).Br J Dermatol 119:597-607, 1988
PubMed
P.215 掲載の参考文献
1) 斉藤輝信:慢性関節リウマチの関節外病変. リウマチ学 (塩川優一編), pp. 571-574, Tokyo, 同文書院, 1989
 
2) 稲冨恵子:呼吸器系への副作用とその対策. リウマチ科 4:160-166, 1990
 
3) Cannon GW:Pulmonary complaints of antirheumatic drug therapy. Semin Arthritis Rheum 19:353-364, 1990
 
4) Zitnik RJ, Cooper JAD Jr:Pulmonary disease due to antirheumatic agents. Clin Chest Med 11:139-150, 1990
 
5) Cooper JAD Jr, White DA, Matthay RA:State of the art; Drug-induced pulmonary disease. Part 1. Cytotoxic drugs. Am Rev Respir Dis 133:321-340, 1986
 
6) Cooper JAD Jr, White DA, Matthay RA:State of the art; Drug-induced pulmonary disease. Part 2. Noncytotoxic drugs, Am Rev Respir Dis 133:488-505, 1986
 
7) 猪熊茂子:金療法による肺病変とリウマトイド肺, リウマチ科 1:352, 1989
 
8) Evans RB, Ettensohn DB, Fawaz-Estrup F, et al:Gold lung:Recent development in pathogenesis, diagnosis, and therapy. Semin Arthritis Rheum 16:196-205, 1987
 
9) 奥田恭章, 高杉潔, 今井淳子, 他:オーラノフィンにて急性間質性肺炎を来した慢性関節リウマチの1例. リウマチ 31:54-61, 1991
 
10) 根岸雅夫, 小林和夫, 井出宏嗣, 他:金剤投与中に間質性肺炎をきたした慢性関節リウマチの1例. 内科 64:771-774, 1989
 
11) Fort JG, Scovern H, Abruzzo JL:Intravenous cyclophosphamide and methylprednisolone for the treatment of bronchiolitis obliterans and interstitial fibrosis associated with crysotherapy. J Rheumatol 15:850-854, 1988
PubMed
12) Davis P, Menard H, Thompson J, et al:One year comperative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis. J Rheumatol 12:60-67, 1985
 
13) 近藤有好:膠原病の肺病変. 内科 55:665-670, 1985
 
14) 会川尚志, 沢口常康, 関久友:金製剤による間質性肺炎と思われる1例. 日胸疾会誌 19:894, 1981
 
15) 工藤宏―郎, 宮本昭正, 堀内淑彦:金製剤によると思われる肺線維症の1症例と気管支喘息患者の金療法中の胸部X線像の検討. 日胸疾会誌 15:646-652, 1977
 
16) 北原多喜:金製剤使用中に発症し, 集団検診で発見された間質性肺炎の1例. 日胸 46:755-760, 1987
 
17) Hakala M, Van Assendelft AHW, Ilonen J, et al:Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis. Ann Rheum Dis 45:177-182, 1986
 
18) 千田守, 泉並木, 新田政男, 他:金塩製剤使用中に発症した肺線維症の1剖検例. 日胸 39:612-616, 1980
 
19) 池田俊, 近沢章二, 直江弘昭, 他:“Gold lung ”の気管支肺胞洗浄液中のT細胞増加とリンホカインについて. 日胸疾会誌 24:1258-1264, 1986
 
20) Costabel V, Senmitz-Schummann M, Matthys H, et al:Bronchoalveolar T-cell subsets in gold lung. Chest 87:135, 1985
 
21) Akoun GM, Herman DP, Milleron BJ, et al:Bronchoalveolar T-cell subsets in gold lung; Evidence for a hypersensitivity reaction. Chest 87:135, 1985
 
22) 大西利明, 南部静洋, 田中栄作, 他:金製剤投与中, 急速に肺線維症が進行した慢性関節リウマチの1症例. 日胸疾会誌 23:1070, 1985
 
23) Camus P, Degat R, Justrabo E, et al:D-penicillamine-induced severe pneumonitis. Chest 81:376-378, 1982
 
24) Lyle WH:D-penicillamine and fatal obliterative bronchiolitis. Br Med J 1:105, 1977
 
25) Stein HB, Patterson AC, Offer RC, et al:Adverse effect of D-penicillamine in rheumatoid arthritis. Ann Intern Med 92:24-29, 1980
PubMed
26) Murphy KC, Atkins CJ, Offer RC, et al:Obliterative bronchiolitis in two rheumatoid arthritis patients treated with penicillamine. Arthritis Rheum 24:557-560, 1981
PubMed
27) Peces R, Riera JR, Arboleya LR, et al:Goodpasture's syndrome in a patient receiving penicillamine and carbimazole. Nephron 45:316-320, 1987
 
28) Louie S, Gamble CN, Cross CE:Penicillamine associated pulmonary hemorrhage. J Rheumatol 13:963-966, 1986
PubMed
29) Shettar SP, Chattopadhyay C, Wolotenholme RJ:Diffuse alveolitis on a small dose of penicillamine. Br J Rheumatol 23:220-240, 1984
 
30) Sany J, Combe B, Verdie-Petibon D, et al:Etude de la tolerance a long terme de la thiopronine dans le traitement de la polyarthrite rhumatoide. Apropos de 140 cas personnels. Rev Rhum 57:105-111, 1990
 
31) 根岸雅夫, 関根富佐夫, 小林和夫, 他:プシラミン治療中に間質性肺炎をきたしたRAの1症例. リウマチ科 2:272-274, 1989
 
32) 早川正勝, 益頭尚道:ブシラミン治療中に間質性肺炎, 自然気胸をきたした慢性関節リウマチの一例. リウマチ 30:654, 199
 
33) 横山良樹, 井上一, 守都義明, 他:ブシラミンの副作用について. リウマチ 30:654:1990
 
34) Amos RS, Pullar T, Bax DE, et al:Sulphasalazine for rheumatoid arthritis; toxicity in 774 patients monitored for one to 11 years. Br Med J 293:420-423, 1986
 
35) Boid O, Gibbs AR, Smith AP:Fibrosing alveolitis due to salphasalazine in a patient with rheumatoid arthritis. Br J Rheumatol 29:222-224, 1990
 
36) Bargon J, Rust M, Kardos P, et al:Salazosulfapyridin-induzierte eosinophile Pneumonie mit pulmonaler und kutaner epitheloidzellige Granulomatose bei Sjogren-Syndrom. Pneumologie 44:744-750, 1990
PubMed
37) Klein HP, Rupp M, Thiele-Fischbach A:Arzneimittel-induzierte Alveolitis durch Salazosulfapyridin. Dtsch Med Wschr 113:1239-1241, 1988
PubMed
38) 波江野茂彦, 志水正敏, 寺西強, 他:低用量MTX療法の有効性と副作用について. 第4回関西リウマチ学会総会プログラム抄録集. p. 80, 1990
 
39) Searles G, McKendry RJR:Methotrexate pneumonitis in rheumatoid arthritis; Potential risk factors. Four case reports and a review of the literature. J Rheumatol 14:1164-1171, 1987
 
40) Kremer JM, Lee JK:The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 29:822-831, 1986
PubMed
41) Carson CW, Cannon GW, Egger MJ, et al:Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Semin Arthritis Rheum 16:186-195, 1987
PubMed
42) St Clair EW, Rice JR, Snyderrnan R:Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis. Arch Intern Med 145:2035-2038, 1985
 
43) Gispen JG, Alarcon GS, Johnson JJ, et al:Toxicity to methotrexate in rheumatoid arthritis. J Rheumatol 14:74-79, 1987
PubMed
44) Williams HJ, Camon GW, Ward JR:Methotrexate induced pulmonary toxicity in patients with rheumatoid arthritis. Rheumatology 9:244-251, 1986
 
45) Ridley MG, Wolfe CS, Mathews JA:Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis:a case report and review of the literature. Ann Rheum Dis 47:784-788, 1988
PubMed
46) Elsasser S, Dalquen P, Soler M, et al:Methotrexate-induced pneumonitis; Appearance four weeks after discontinuation of treatment. Am Rev Respir Dis 140:1089-1092, 1989
PubMed
47) Sostman HD, Matthay RA, Putman CE:Methotrexate induced pneumonitis. Medicine 55:371-388, 1976
PubMed
48) Ayres JG, Fleming DM, Whittington RM:Asthma death due to ibuprofen. Lancet 1:1082, 1987
 
49) Buscaglia AJ, Cowden FE, Brill H:Pulmonary infiltrates associated with naproxen. JAMA 251:65-66, 1984:
PubMed
50) Fein M:Letter to the Editor. Sulindac and pneumonitis. Ann Intern Med 95:245, 1981
 
51) White DA, Rankin JA, Stover DE, et al:Methotrexate pneumonitis. Am Rev Respir Dis 139:18-21, 1989
PubMed
52) 山田順子, 斉藤吉人, 渡辺哲造, 他:金塩による肺線維症とBALによる治療経験. 日胸 40:533-538, 1980
 
53) Gibson T, Burry HC, Ogg C:Goodpasture's syndrome and D-penicillamine. Ann Intern Med 84:100, 1976
 
54) Pesce C, Mansi, C, Bogliolo G, et al:Pulmonary toxicity in mice after hyper-does methotrexate administration with and without leucovorin rescue. Eur J Cancer Clin Oncol 21:875-880, 1985
 
55) Pasquinucci G, Ferrara P, Castellari R:Daunorubicin treatment of methotrexate pneumonia. JAMA 216:2017, 1971
PubMed
56) Mackinnon SK, Starkebaum G, Willkens RF:Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis. Semin Arthritis Rheum 15:119-126, 1985
PubMed
57) 宮地純樹, 岩井和郎, 牧野左平, 他:金製剤使用中に発症した間質性肺炎に関する研究. 日胸疾会誌 13:653-662, 1975
 
P.222 掲載の参考文献
1) Hench PS, Kendall EC, Slocumb CH, et al:The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone 0:Compoumd E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis; Preliminary report. Proc Staff Mtg Mayo Clin 24:181-198, 1949
 
2) Harris ED Jr, Emkey RD, Nichols JE, et al:Low dose prednisone therapy in rheumatoid arthritis. J Rheumatol 10:713-721, 1983
PubMed
3) Bollet AJ, Black R, Bunium JJ:Major undesirable side-effects resulting from prednisolone and prednisone. JAMA 158:459-463, 1955
 
4) Caldwell JR and Furst DE:The efficacy and safety of low-dose cortico-steroids for rheumatoid arthritis. Sem Arthritis Rheum 21:1-11, 1991
 
5) Harn TJ, Boisseau VC, Avioli LV:Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass. J Clin Endocrinol Metab 39:274-282, 1974
 
6) Caniggia A, Nuti R, Lore:F, et al:Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man. J Steroid Biochem 15:153-161, 1981
 
7) 市川陽―, 山田秀裕, 鈴木康夫:ステロイド骨粗鬆症. 骨と関節 2:18-21, 1988
 
8) Dykman TR, Gluck OS, Murphy WA, et al:Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 28:361-368, 1985
PubMed
9) Hooyman JR, Melton III LJ, Nelson AM, et al:Fractures after rheumatoid arthritis; a population-based study. Arthritis Rheum 27:1353-1361, 1984
 
10) Joint Committee:Acomparison of prednisolone with aspirin or other anal-gesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 18:173-188, 1959
 
11) Joint Committee:Acomparison of prednisolone with aspirin or other anal-gesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 19:331-337, 1960
 
12) Liebling MR, Lieb E, McLaughlin K, et al:Pulse methylprednisolone in rheumatoid arthritis. Ann Intern Med 94:21-26, 1981
 
13) Hansen TH, Kryger P, Elling H, et al:Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with modifying drugs in rheumatoid arthritis. Br Med J 4:268-270, 1990
 
14) Corkill MM, Kirkham BW, Chikanza IC, et al:Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis; A24-week randomized controlled trial. Br J Rheumatol 29:274-279, 1990
 
15) Brook A and Corbett M:Radiographic changes in early rheumatoid disease. Ann Rheum Dis 36:71-73, 1977
PubMed
16) Amos RS, Constable TJ, Crockson RA, et al:Rheumatoid arthritis; relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J 1:195-197, 1977
 
17) Dawes PT, Fowler PD, Clarke S, et al:Rheumatoid arthritis; Treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol 25:44-49, 1986
 
18) Sigler JW, Bluhm GB, Dmcan H, et al:Gold salts in the treatment of rheumatoid arthritis; a double blind study. Ann Intern Med 80:21-26, 1974
 
19) Pullar T, Hunter JA, Capell HA:Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis 43:18-23, 1984
PubMed
20) Nordstrom DM, West SG, Andersen PA, et al:Pulse methotrexate therapy in rheumatoid arthritis; A controlled prospective roentgenographic study. Ann Intern Med 107:797-801, 1987
PubMed
P.229 掲載の参考文献
1) Felson DT, Anderson JJ, Meenan RF:The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum 33:1449-1461, 1990
PubMed
2) Zurek WZ, Ojima Y, Anderson LL, Collins GJ, Oberfield RA, Sullivan RD:Pharmacologic studies of methotrexate in man. Sury Gynec Obstet 126:331-338, 1968
 
3) Sutow WW:Osteosarcomaに対するMTX大量療法を中心とした化学療法について. 日本レダリー株式会社開発部編, 1978
 
4) Scully CJ, Anderson CJ, Cannon GW:Long-term methotrexate therapy for rheumatoid arthritis. Semin Arthritis Rheum 20:317-331, 1991
PubMed
5) Gubner R, August S, Ginsberg V:Therapeutic suppression of tissue reactivity. II. Effect of aminopterin rheumatoid arthritis and psoriasis. Am J Med Sci 211:176-182, 1951
 
P.237 掲載の参考文献
1) Moll JMH:Management of rheumatic disorders. Chapman and Hall, London, 1983
 
2) Harris R:Rehabilitation in arthritis and physical medicine. Elizabeth, Licht, pp. 458-481, 1969
 
3) Wickersham BA:The exercise program:Rheumatic disease, Rehabilitation and management (Ed. Ket-shner G, et al), pp. 115-129, Boston, Butterworth, 1984
 
4) Hollander JL:Rheumatoid arthritis:Rheumatic disease; Rehabilitation and management (Ed, Kershner G, et al), pp. 409-418, Butterworth, Boston, 1984
 
5) Hicks JE:Exercise in patients with inflammatory arthritis and connective tissue disease. Rheuma Dis Clinic North America 16:845-870, 1990
 
6) Ekblom B, Lovgrou O, Alderin M, et al:Effect of short term physical training in patients with rheumatoid arthritis. Scand J Rheum 80-91, 1975
 
7) Harkcom TM, Lampman RM, Banwell BF, et al:Therapeutic value of graded aerobic exercise training in rheumatoid arthritis. Arthritis Rheum 28:32-39, 1985
PubMed
8) Jackel WH, Cziske R, Schochat TH, et al:Assessing health status after inpatient rehabilitation in rheumatoid arthritis. Int Rehabil Med 8:54-59, 1986
 
9) Lyngberg K, Danneskiold-Samsoe B, Halskoo O:The effect of physical training on patients with rheumatoid arthritis. Clin exper Rheumatol 253-260, 1988
 
10) Danneskiold-Samsoe B, Lyngberg K, Risum T, et al:The effect of water exercise therapy given to patients with rheumatoid arthritis. Seand J Rehab Med 19:31-35, 1987
 
11) Perlman SG, Connell KJ, Clark A, et al:Dance-based aerobic exercise for rheumatoid arthritis. Arthritis Care and Research 3:29-35, 1990
PubMed
12) Kartou I, Lee M, Mceven C:Rheumatoid arthritis; Five years study of rehabilitation. Arch phys Med rehabil, pp. 120-128, 1973
 
13) De Blecourt JJ, Wood PHN, Badley EM:Aims of Rehabilitation for Rheumatic Patients. Clin Rheum Dis 7:291-293, 1981
 
14) Mowat AG, Nichols PJR, Hollings EM, et al:A comparison of follow-up regimes in rheumatoid arthritis. Ann Rheum Dis 39:12-17, 1980
 
15) Cosgrove JL, Nicholas JJ, Barmak J, et al:Does a specialized unit improve team performance? Amer J phys Med&Rehabili, pp. 253-260, 1988
 
16) Nordemar R:Physical training in rheumatoid arthritis:A controlled long-term study. Scand J Rheumatol 10:25-30, 1981
PubMed
17) Nordemar R, Ekblom B, Zachrisson L, et al:Physical training in rheumatoid arthritis; A controlled long-term study. I. Scand J Rheumatol 10:17-23, 1981
PubMed
18) Ekblom B:Short and long-term physical training in patients with rheumatoid arthritis. Scand J Rheumatol, pp. 109-110, 1982
 
19) Spiegel JS, Spiegel TM, Ward NB, Paulus HE, et al:Rehabilitation for rheumatoid arthritis patients. Arthritis Rheum 29:628-637, 1986
PubMed
20) Minor MA, Hewett JE, Webel RR, et al:Exercise tolerance and disease related measures in patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 15:905-911, 1988
PubMed
21) Minor MA, Hewett JE, Webel RR, et al:Efficacy of physical conditioning exercise in patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 32:1396-1405, 1989
PubMed
22) Haralson K:Physical Therapy and Arthritis. Arthritis Care and Research 3:173-177, 1990
 
23) Brighton SW, De La Harpe AL, Low E, et al:The team approach to rheumatoid arthritis. SA Med J, pp. 864-865, 1981
 
24) Katz WA:Modern management of rheumatoid arthritis. Amer J Med 24-31, 1985
PubMed
P.243 掲載の参考文献
1) Ghormley RK:Low back pain with special reference to the articular facets with presentation of an operative procedure. J A M A 101:1773, 1933
 
2) 中川一刀:脊椎分離症･すべり症の発痛序に関する臨床的研究. 日整会誌 44:99, 1970
 
3) Shealy CN:The role of the spinal facets in back and sciatic pain. Headache 14:101, 1974
 
4) McCulloch JA:Percutaneous radio-frequency lumbar rhizolysis. Appl Neuro-physiol 39:87, 1976
 
5) 大瀬戸清茂, 湯田康正:腰椎々間関節性腰痛に対するfacet rhizotomyの検討. 中部整災誌 32:164, 1989
 
6) Shealy CN:Facet denervation in the management of back and sciatic pain. Clin Orthop 115:157-164, 1976
PubMed
7) Ogssbury JS, Simon RH, Lehman RA:Facet denervation in the low-back syndrome. Pain 3:257-263, 1977
 
8) McCulloch JA:Percutaneous radiofrequency lumbar rhizolysis (Rhizotomy). Can Med Ass J 16:30-32, 1977
 
9) Selby D, Paris S:Anatomy of facet joints and its clinical correlation with low-back pain. Contemporary Orthop 312:1097-1103, 1981
 
10) Lavignolle B, Senegas J, Honton JL, et al:Denervation percutanee; radiofrequence des facettes articulaires lombaires dans les lombalgies. Rachis 1:31-40, 1989
 
11) Garvey TA, Marks MR, Wiesel SW:A prospective randomized double blind evaluation of trigger point injection therapy of low-back pain. Spine 14:962-964, 1989
PubMed

手術

P.264 掲載の参考文献
1) 渡辺 弘, 氏家秀夫, 広畑和志:人工関節のアメリカ市場の調査について. 平成3年度厚生省リウマチ調査研究事業研究報告書, pp. 258-259, 1992
 
2) Coombs R, Gristina A, Hungerford D, ed:Joint replacement-State of the art. London, Orthotext, 1990
 
3) Kapandji IA:The elbow. in The physiology of the joints. vol. 1 Upper limb 5th ed. (translated by Honore LH), pp. 72-97, Edinburgh, Churchill-Livingstone, 1982
 
4) 村田秀雄:ADLにおける肘関節の可動域. 整形外科MOOK No54, pp. 17-25, 南江堂, 1988
 
5) 小川亮恵:リウマチの上肢の手術. 関節外科 9:731-737, 1990
 
6) O'Neill OR, Morrey BF, Tanaka S, et al:Compensatory motion in the upper extremity after elbow arthrodesis. Clin Orthop 281:89-96, 1992
 
7) 居村茂明, 綿谷和男:<人工関節>肘. 隔月刊-関節外科 4:415-420, 1985.
 
8) Coonrad RW:Comments on the historical milestones in the development of elbow arthroplasty:Indication and complications. in American Academy of Orthopaedic Surgeons Instructional Course Lectures, XL, pp. 51-55, St. Louis, CV Mosby, 1990
 
9) Souter WA:The evolution of total replacement arthroplasty of the elbow. in Elbow joint (Ed, Kashiwagi D), pp. 255-268, Amsterdam, Elsevier Science Publisher BV, 1985
 
10) Souter WA:Surgery of the rheumatoid elbow. Ann Rheum Dis 49:871-882, 1990
PubMed
11) Inoue H, Yokoyama Y, Sumii H:Elbow arthroplasty with ceramic prostheses. Techniques Orthop 6:27-32, 1991
 
12) 工藤洋:RAに対する人工肘関節の適応, 成績および最近の進歩. 関節外科 9:747-756, 1990
 
13) 居村茂明:非制動型人工肘 (加古川) によるリウマチ肘の治療. 日関外誌 1:185-190, 1982
 
14) Imura S, Watatani K:Aloose-hinged artificial elbow (Kakogawa) in the treatment of rheumatoid elbows. in Elbow joint (Ed, Kashiwagi, D), pp. 277-283, Amsterdam, Elsevier Science Publishe BV, 1985
 
15) 居村茂明:肘人工関節形成術 (加古川型) と治療成績. 整形外科MOOK No54, pp. 301-308, 南江堂, 1988
 
16) Ferlic DC:Management of the rheumatoid elbow. in Surgery for rheumatoid arthritis (Ed, Clayton ML, Smyth CJ), PP. 133-154, New York, Churchill Livingstone, 1992
 
17) Swanson AB, Herndon JH:Surgery of arthritis. in The elbow (Ed, Wadsworth TB), pp. 303-345, London, Churchill Livingstone, 1982
 
18) 木村千仭, 工藤洋:肘関節の手術. 関節リウマチの外科 (山本真, 木村千仭, 田中清介監修), pp. 83-93, 南江堂, 1990
 
19) 浅井富明, 塚本正美, 斉藤進ら:リウマチ肘関節の滑膜切除術. 関節外科 9:739-745, 1990
 
20) 小村孝, 西林保朗, 水口龍次ら:橈骨頭silastic implantを用いた肘関節滑膜切除術の成績. 第3回日本肘関節研究会口演･討論要旨, pp. 53-55, 1991
 
21) 梁瀬義章, 田中清介:外科的治療法の種類と意義. 関節リウマチの外科 (山本真, 木村千便, 田中清介監修), pp. 9-24, 南江堂, 1990
 
22) 吉岡秀夫, 天野祐一, 金井秀彰ら:椀骨頭を温存したRA肘関節滑膜切除の工夫 (津下変法).臨床リウマチ 3:216-220, 1990
 
23) 津下健哉:肘関節へのアプローチ, 南江堂, 1991
 
24) Ogawa R:Synovectomy of the elbow joint and its follow-up study. in Elbow joint (Ed, Kashiwagi, D), pp. 217-223, Amsterdam, Elsevier Science Publishers BV, 1985
 
25) Dennis DA, Clayton ML, Ferlic DC, et al:Capitello-condylar total elbow arthroplasty for rheumatoid arthritis. J Arthroplasty, 5 (Suppl):83-88, 1990
 
26) 司馬良一:人工関節形成術に必要な肘関節の構造とバイオメカニクス. 整形外科MOOK No54, pp. 291-300, 南江堂, 1988
 
27) Inglis AE:Total elbow arthroplasty advances and techniques. Techniques Orthop 6:19-26, 1991
 
28) 藤田雅之, 西林保朗, 庄智矢ら:慢性関節リウマチにおける加古川マークIII人工肘関節置換術の成績. 臨床リウマチ 3:48-55, 1990
 
29) 久保仁志, 西林保朗, 水口龍次ら:加古川マークIII人工肘関節置換術の問題点. 第3回日本肘関節研究会口演討論・要旨, pp. 65-67, 1991
 
30) 西林保朗, 七川歓次, 西岡淳一ら:慢性関節リウマチにおける加古川マークIII人工肘関節置換術の経験. 日関外誌 1:243-251, 1982
 
31) Maloney WJ, Schurman DJ:Cast immobilization after total elbow arthroplasty. Clin Orthop 245:117-122, 1989
PubMed
32) 西林保朗:RAにおける加古川型人工肘関節のSurvival Rate. 平成3年度厚生省リウマチ調査研究事業研究報告書, pp. 250-252, 1992
 

書評

最近チェックした商品履歴

Loading...